10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the transition period from _____to _____

Commission File Number 001-36801

Qorvo, Inc.

(Exact name of registrant as specified in its charter) 

Delaware		46-5288992
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
7628 Thorndike Road
Greensboro,	North Carolina	27409-9421
(Address of principal executive offices)		(Zip Code)

(336) 664-1233

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.0001 par value	QRVO	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	þ	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

As of October 26, 2023, there were 97,345,755 shares of the registrant’s common stock outstanding.

QORVO, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

	Page
PART I — FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited).
Condensed Consolidated Balance Sheets	4
Condensed Consolidated Statements of Income	5
Condensed Consolidated Statements of Comprehensive Income	6
Condensed Consolidated Statements of Stockholders' Equity	7
Condensed Consolidated Statements of Cash Flows	9
Notes to Condensed Consolidated Financial Statements	10
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.	20
Item 3. Quantitative and Qualitative Disclosures About Market Risk.	29
Item 4. Controls and Procedures.	29
PART II — OTHER INFORMATION
Item 1A. Risk Factors.	30
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.	30
Item 5. Other Information.	31
Item 6. Exhibits.	32
SIGNATURES	33

3

PART I — FINANCIAL INFORMATION

ITEM 1.

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)

 

	September 30, 2023		April 1, 2023
ASSETS
Current assets:
Cash and cash equivalents	$	706,836	$	808,757
Accounts receivable, net of allowance of $494 and $369 as of September 30, 2023 and April 1, 2023, respectively	592,738		304,519
Inventories	839,855		796,596
Prepaid expenses	49,120		46,684
Other receivables	27,888		26,535
Other current assets	46,440		46,703
Total current assets	2,262,877		2,029,794
Property and equipment, net of accumulated depreciation of $1,976,429 and $1,900,317 as of September 30, 2023 and April 1, 2023, respectively	1,061,163		1,149,806
Goodwill	2,708,310		2,760,813
Intangible assets, net	473,164		537,703
Long-term investments	25,649		20,406
Other non-current assets	187,357		193,381
Total assets	$	6,718,520	$	6,691,903
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	275,256	$	210,701
Accrued liabilities	303,810		222,463
Other current liabilities	92,876		122,599
Total current liabilities	671,942		555,763
Long-term debt	2,048,585		2,048,073
Other long-term liabilities	180,807		185,273
Total liabilities	2,901,334		2,789,109
Commitments and contingent liabilities (Note 7)
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	—		—
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 97,506 and 98,649 shares issued and outstanding at September 30, 2023 and April 1, 2023, respectively	3,796,189		3,821,474
Accumulated other comprehensive loss	(13,609)		(3,175)
Retained earnings	34,606		84,495
Total stockholders’ equity	3,817,186		3,902,794
Total liabilities and stockholders’ equity	$	6,718,520	$	6,691,903

See accompanying Notes to Condensed Consolidated Financial Statements.

4

 QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Revenue	$	1,103,493	$	1,158,057	$	1,754,657	$	2,193,415
Cost of goods sold	613,803		619,130		1,035,897		1,279,238
Gross profit	489,690		538,927		718,760		914,177
Operating expenses:
Research and development	174,947		168,164		338,037		336,732
Selling, general and administrative	103,696		97,752		209,119		199,567
Other operating expense	59,619		11,449		68,312		14,457
Total operating expenses	338,262		277,365		615,468		550,756
Operating income	151,428		261,562		103,292		363,421
Interest expense	(17,121)		(16,904)		(34,382)		(34,156)
Other income (expense), net	5,211		2,214		18,927		(2,848)
Income before income taxes	139,518		246,872		87,837		326,417
Income tax expense	(42,057)		(58,257)		(33,956)		(68,918)
Net income	$	97,461	$	188,615	$	53,881	$	257,499
Net income per share:
Basic	$	1.00	$	1.83	$	0.55	$	2.48
Diluted	$	0.99	$	1.82	$	0.54	$	2.46
Weighted-average shares of common stock outstanding:
Basic	97,945		102,927		98,167		103,991
Diluted	98,590		103,674		98,892		104,817

See accompanying Notes to Condensed Consolidated Financial Statements.

5

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Net income	$	97,461	$	188,615	$	53,881	$	257,499
Other comprehensive loss, net of tax:
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature	(9,569)		(23,811)		(10,428)		(47,026)
Reclassification adjustments, net of tax:
Amortization of pension actuarial (gain) loss	(3)		9		(6)		18
Other comprehensive loss	(9,572)		(23,802)		(10,434)		(47,008)
Total comprehensive income	$	87,889	$	164,813	$	43,447	$	210,491

See accompanying Notes to Condensed Consolidated Financial Statements.

6

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands)

(Unaudited)

				Accumulated Other Comprehensive Loss		Retained Earnings
	Common Stock
Three Months Ended	Shares	Amount						Total
Balance, July 1, 2023	98,048	$	3,816,260	$	(4,037)	$	—	$	3,812,223
Net income	—	—		—		97,461		97,461
Other comprehensive loss	—	—		(9,572)		—		(9,572)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	427	(19,741)		—		—		(19,741)
Repurchase of common stock, including transaction costs and excise tax	(969)	(37,699)		—		(62,855)		(100,554)
Stock-based compensation	—	37,369		—		—		37,369
Balance, September 30, 2023	97,506	$	3,796,189	$	(13,609)	$	34,606	$	3,817,186
Balance, July 2, 2022	103,340	$	3,962,499	$	(17,974)	$	356,080	$	4,300,605
Net income	—	—		—		188,615		188,615
Other comprehensive loss	—	—		(23,802)		—		(23,802)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	372	(16,993)		—		—		(16,993)
Repurchase of common stock, including transaction costs	(1,651)	(63,309)		—		(96,748)		(160,057)
Stock-based compensation	—	33,772		—		—		33,772
Balance, October 1, 2022	102,061	$	3,915,969	$	(41,776)	$	447,947	$	4,322,140

See accompanying Notes to Condensed Consolidated Financial Statements.

7

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands)

(Unaudited)

				Accumulated Other Comprehensive (Loss) Income		Retained Earnings
	Common Stock
Six Months Ended	Shares	Amount						Total
Balance, April 1, 2023	98,649	$	3,821,474	$	(3,175)	$	84,495	$	3,902,794
Net income	—	—		—		53,881		53,881
Other comprehensive loss	—	—		(10,434)		—		(10,434)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	597	(24,163)		—		—		(24,163)
Issuance of common stock in connection with employee stock purchase plan	262	19,180		—		—		19,180
Repurchase of common stock, including transaction costs and excise tax	(2,002)	(97,396)		—		(103,770)		(201,166)
Stock-based compensation	—	77,094		—		—		77,094
Balance, September 30, 2023	97,506	$	3,796,189	$	(13,609)	$	34,606	$	3,817,186
Balance, April 2, 2022	106,303	$	4,035,849	$	5,232	$	512,137	$	4,553,218
Net income	—	—		—		257,499		257,499
Other comprehensive loss	—	—		(47,008)		—		(47,008)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	509	(21,181)		—		—		(21,181)
Issuance of common stock in connection with employee stock purchase plan	195	18,893		—		—		18,893
Repurchase of common stock, including transaction costs	(4,946)	(188,410)		—		(321,689)		(510,099)
Stock-based compensation	—	70,818		—		—		70,818
Balance, October 1, 2022	102,061	$	3,915,969	$	(41,776)	$	447,947	$	4,322,140

See accompanying Notes to Condensed Consolidated Financial Statements.

8

QORVO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Six Months Ended
	September 30, 2023		October 1, 2022
Cash flows from operating activities:
Net income	$	53,881	$	257,499
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	99,183		103,882
Intangible assets amortization	61,103		66,539
Deferred income taxes	1,629		(16,693)
Stock-based compensation expense	77,498		67,203
Other, net	64,377		58,804
Changes in operating assets and liabilities:
Accounts receivable, net	(288,221)		(75,728)
Inventories	(45,694)		(81,716)
Prepaid expenses and other assets	(2,547)		30,503
Accounts payable and accrued liabilities	148,616		65,012
Income taxes payable and receivable	(9,674)		3,518
Other liabilities	(22,253)		61,601
Net cash provided by operating activities	137,898		540,424
Cash flows from investing activities:
Purchase of property and equipment	(68,076)		(90,454)
Proceeds from sales of property and equipment	47,301		331
Other investing activities	(3,418)		5,841
Net cash used in investing activities	(24,193)		(84,282)
Cash flows from financing activities:
Repurchase of common stock, including transaction costs	(200,026)		(510,099)
Proceeds from the issuance of common stock	21,041		19,541
Tax withholding paid on behalf of employees for restricted stock units	(25,472)		(22,020)
Other financing activities	(9,854)		(379)
Net cash used in financing activities	(214,311)		(512,957)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,501)		(4,237)
Net decrease in cash, cash equivalents and restricted cash	(102,107)		(61,052)
Cash, cash equivalents and restricted cash at the beginning of the period	808,943		972,805
Cash, cash equivalents and restricted cash at the end of the period	$	706,836	$	911,753
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	$	706,836	$	911,570
Restricted cash included in "Other current assets" and "Other non-current assets"	—		183
Total cash, cash equivalents and restricted cash	$	706,836	$	911,753
Supplemental disclosure of cash flow information:
Capital expenditures included in liabilities	$	27,610	$	26,658

See accompanying Notes to Condensed Consolidated Financial Statements.

9

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying Condensed Consolidated Financial Statements of Qorvo, Inc. and Subsidiaries (together, the "Company" or "Qorvo") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). The preparation of these financial statements requires management to make estimates and assumptions, which could differ materially from actual results. In addition, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the United States Securities and Exchange Commission (the "SEC"). In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. These Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended April 1, 2023.

The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company operates under three segments, High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG").

Certain prior period amounts have been reclassified to conform to the fiscal 2024 presentation.

The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. Each fiscal year, the first quarter ends on the Saturday closest to June 30, the second quarter ends on the Saturday closest to September 30 and the third quarter ends on the Saturday closest to December 31. Fiscal years 2024 and 2023 are 52-week years.

2. INVENTORIES

The components of inventories, net of reserves, are as follows (in thousands):

	September 30, 2023		April 1, 2023
Raw materials	$	266,354	$	264,367
Work in process	421,295		345,545
Finished goods	152,206		186,684
Total inventories	$	839,855	$	796,596

3. GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill are as follows (in thousands):

	HPA		CSG		ACG		Total
Balance as of April 1, 2023 (1)	$	501,602	$	525,351	$	1,733,860	$	2,760,813
Goodwill impairment	—		(48,000)		—		(48,000)
Effect of changes in foreign currency exchange rates	—		(4,503)		—		(4,503)
Balance as of September 30, 2023 (1)	$	501,602	$	472,848	$	1,733,860	$	2,708,310

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $730.0 million and $682.0 million as of September 30, 2023 and April 1, 2023, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023 and 2024.

During the second quarter of fiscal 2024, the Company completed an interim test for goodwill impairment as management determined, based on revisions to long-term forecasts, it was more likely than not that the fair value of a reporting unit within the CSG segment was below its carrying amount. The quantitative analysis, which considered the income approach and the market approach to estimate the reporting unit's fair value, resulted in a goodwill impairment charge of approximately $48.0 million, which was recorded in "Other operating expense" in the Condensed Consolidated Statements of Income.

10

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):

	September 30, 2023				April 1, 2023
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	863,836	$	430,265	$	872,106	$	382,448
Customer relationships	87,040		58,551		104,616		67,485
Technology licenses	2,224		703		1,664		513
Trade names	910		901		910		789
In-process research and development	9,574		N/A		9,642		N/A
Total (1)	$	963,584	$	490,420	$	988,938	$	451,235

(1) Amounts include the impact of foreign currency translation.

At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets.

4. INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS

Equity Method Investments

The Company invests in limited partnerships and accounts for these investments using the equity method. The carrying amounts of these investments, as of September 30, 2023 and April 1, 2023 were $18.5 million and $20.4 million, respectively, and are classified as "Long-term investments" in the Condensed Consolidated Balance Sheets. During the three and six months ended September 30, 2023, the Company recorded a loss of $1.2 million and income of $0.9 million, respectively, based on its share of the limited partnerships' results. During the three and six months ended October 1, 2022, the Company recorded income of $1.2 million and $0.4 million, respectively, based on its share of the limited partnerships' results. These amounts are included in "Other income (expense), net" in the Condensed Consolidated Statements of Income. During the three and six months ended September 30, 2023, the Company received cash distributions of $2.3 million and $2.8 million, respectively, from these limited partnerships. No cash distributions were received during the three months ended October 1, 2022 and $2.0 million of cash distributions were received during the six months ended October 1, 2022. The cash distributions were recognized as reductions to the carrying value of the investments and included in the cash flows from investing activities in the Condensed Consolidated Statements of Cash Flows.

11

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

Fair Value of Financial Instruments

The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands):

	Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
September 30, 2023
Marketable equity securities	$	642	$	642	$	—	$	—
Invested funds in deferred compensation plan (1)	42,939		42,939		—		—
April 1, 2023
Marketable equity securities	$	1,094	$	1,094	$	—	$	—
Invested funds in deferred compensation plan (1)	40,653		40,653		—		—
Contingent earn-out liability (2)	(31,250)		—		—		(31,250)

(1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments.

(2) The fair value of the contingent consideration liability which related to the acquisition of United Silicon Carbide, Inc. was equal to the maximum amount payable at April 1, 2023 and was subsequently paid in the first quarter of fiscal 2024.

5. LONG-TERM DEBT

Long-term debt is as follows (in thousands):

	September 30, 2023		April 1, 2023
1.750% senior notes due 2024	$	500,000	$	500,000
4.375% senior notes due 2029	850,000		850,000
3.375% senior notes due 2031	700,000		700,000
Finance leases and other	1,238		1,666
Unamortized premium, discount and issuance costs, net	(2,557)		(3,283)
Less current portion of long-term debt	(96)		(310)
Total long-term debt	$	2,048,585	$	2,048,073

Credit Agreement

On September 29, 2020, the Company and certain of its U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "Credit Agreement") with Bank of America, N.A., acting as administrative agent, and a syndicate of lenders. The Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017. The Credit Agreement includes a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million, and included a senior term loan that was fully repaid in fiscal 2022. The Revolving Facility is available to finance working capital, capital expenditures and other general corporate purposes.

Pursuant to the Credit Agreement, the Company may request one or more additional tranches of term loans or increases to the Revolving Facility, up to an aggregate of $500.0 million and subject to, among other things, securing additional funding commitments from the existing or new lenders.

On April 6, 2022, the Company and the administrative agent entered into an amendment to the Credit Agreement (the "LIBOR Transition Amendment") to replace the London Interbank Offered Rate as a reference rate available for use in the computation of interest under the Credit Agreement. As a result of the LIBOR Transition Amendment, at the Company’s option, loans

12

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

under the Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus the Term SOFR (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate as set by the administrative agent, and (c) the Term SOFR plus 1.0% (the "Base Rate"). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Term SOFR is the rate per annum equal to the forward-looking Secured Overnight Financing Rate term rate for interest periods of one, three or six months (as selected by the Company) plus an adjustment (as defined in the Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.250% per annum, and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.250% per annum. Undrawn amounts under the Revolving Facility are subject to a commitment fee ranging from 0.150% to 0.200%.

On June 23, 2023, the Company entered into a second amendment to the Credit Agreement (the "Second Amendment"). The purpose of the Second Amendment was to amend certain covenants related to the Company’s ratio of Consolidated Funded Indebtedness to Consolidated EBITDA, as such terms are defined in the Credit Agreement (the "Consolidated Leverage Ratio"). The Second Amendment increased the maximum Consolidated Leverage Ratio to 4.00 to 1.00 for the fiscal quarters ended July 1, 2023 and September 30, 2023, and 3.50 to 1.00 for the fiscal quarters ending December 30, 2023 and March 30, 2024. For subsequent fiscal quarters, the maximum Consolidated Leverage Ratio will return to 3.00 to 1.00.

During the three and six months ended September 30, 2023, there were no borrowings under the Revolving Facility.

The Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and to avoid an event of default. As of September 30, 2023, the Company was in compliance with these covenants.

Senior Notes due 2024

On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The 2024 Notes were issued pursuant to an indenture, dated as of December 14, 2021 (the "2021 Indenture"), by and among the Company, the Guarantors and Computershare Trust Company, N.A., as trustee. The 2021 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants.

In connection with the offering of the 2024 Notes, the Company entered into a Registration Rights Agreement, dated as of December 14, 2021 (the "Registration Rights Agreement"), by and among the Company and the Guarantors, on the one hand, and BofA Securities, Inc., as representative of the initial purchasers of the 2024 Notes, on the other hand.

On September 13, 2023, pursuant to their obligations under the Registration Rights Agreement, the Company and the Guarantors filed with the SEC a registration statement relating to the registered exchange offer (the "Exchange Offer") to exchange the 2024 Notes for a new series of the Company's exchange notes having terms substantially identical in all material respects to, and in the same aggregate principal amount as, the 2024 Notes. On October 16, 2023, the Company and the Guarantors commenced the Exchange Offer, which is scheduled to expire on November 17, 2023, unless extended.

Interest is payable on the 2024 Notes on June 15 and December 15 of each year. The Company paid no interest on the 2024 Notes during the three months ended September 30, 2023 and October 1, 2022, and paid interest of $4.4 million during both the six months ended September 30, 2023 and October 1, 2022.

Senior Notes due 2029

On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and collectively with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in

13

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019, and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture.

Interest is payable on the 2029 Notes on April 15 and October 15 of each year. The Company paid no interest on the 2029 Notes during the three months ended September 30, 2023 and October 1, 2022, and paid interest of $18.6 million during both the six months ended September 30, 2023 and October 1, 2022.

Senior Notes due 2031

On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture.

Interest is payable on the 2031 Notes on April 1 and October 1 of each year. The Company paid no interest on the 2031 Notes during the three and six months ended September 30, 2023, and paid interest of $11.8 million during the three and six months ended October 1, 2022.

Fair Value of Long-Term Debt

The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of September 30, 2023 was $470.7 million, $751.1 million and $553.8 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 1, 2023 was $464.2 million, $785.9 million and $565.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

Interest Expense

During the three and six months ended September 30, 2023, the Company recognized $17.9 million and $36.1 million of interest expense, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $0.8 million and $1.7 million, respectively. During the three and six months ended October 1, 2022, the Company recognized $17.9 million and $36.1 million of interest expense, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $1.0 million and $2.0 million, respectively.

14

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

6. STOCK REPURCHASES

On November 2, 2022, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization.

Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended, or terminated at any time without prior notice. As of January 1, 2023, the Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. The excise tax is recognized as part of the cost basis of shares acquired in the Condensed Consolidated Statements of Stockholders' Equity.

During the three and six months ended September 30, 2023, the Company repurchased approximately 1.0 million and 2.0 million shares of its common stock, respectively, for approximately $100.6 million and $201.2 million, respectively (including transaction costs and excise tax) under the current share repurchase program. As of September 30, 2023, approximately $1,505.0 million remains available for repurchases under the current share repurchase program.

During the three and six months ended October 1, 2022, the Company repurchased approximately 1.7 million and 4.9 million shares, respectively, of its common stock for approximately $160.1 million and $510.1 million, respectively (including transaction costs) under the prior share repurchase program.

7. COMMITMENTS AND CONTINGENT LIABILITIES

In fiscal 2022, the Company entered into a long-term capacity reservation agreement with a foundry supplier to purchase a certain number of wafers through calendar year 2025. In fiscal 2023, the agreement was amended and the term was extended through calendar year 2026. In the first quarter of fiscal 2023, the Company recorded charges of $110.0 million to "Cost of goods sold" based on the actual and estimated purchase shortfalls. No charges have been recorded to the Condensed Consolidated Statements of Income in the first quarter or second quarter of fiscal 2024 as a result of this agreement.

In October 2023, the long-term capacity reservation agreement with the foundry supplier was further amended. Pursuant to the amendment, the Company is no longer obligated to order silicon wafers from the foundry supplier and the agreement will be terminated effective December 31, 2023. A contract termination fee of $65.0 million will be recorded to “Cost of goods sold” in the third quarter of fiscal 2024 and is expected to be paid by the Company during the fourth quarter of fiscal 2024.

Legal Matters

The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

15

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

8. REVENUE

Revenue to customers by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
United States	$	699,288	$	615,007	$	1,014,571	$	1,011,038
China	189,900		221,737		340,706		505,213
Other Asia	119,395		126,360		210,729		318,688
Taiwan	66,162		130,463		132,018		221,635
Europe	28,748		64,490		56,633		136,841
Total revenue	$	1,103,493	$	1,158,057	$	1,754,657	$	2,193,415

The Company also disaggregates revenue by operating segments (refer to Note 10).

9. RESTRUCTURING

During fiscal 2023, the Company initiated actions to improve efficiencies in its operations and further align the organization with its strategic objectives. These initiatives included seeking strategic alternatives related to its non-core biotechnology business. In the second quarter of fiscal 2024, it was determined that this business met the held for sale criteria under ASC 360, "Property, Plant and Equipment," and the sale of this business was subsequently completed in October 2023.

The Company will continue to evaluate its operating footprint, cost structure and strategic opportunities, but does not expect to incur additional material charges related to its 2023 restructuring initiatives. The restructuring charges recorded by the Company are not allocated to its reportable segments.

The following table summarizes the charges resulting from restructuring initiatives (in thousands):

	Three Months Ended September 30, 2023						Six Months Ended September 30, 2023
	Cost of Goods Sold		Other Operating Expense		Total		Cost of Goods Sold		Other Operating Expense		Total
Contract termination and other costs	$	2,482	$	1,328	$	3,810	$	19,278	$	2,757	$	22,035
Asset impairment costs	—		3,646		3,646		2,159		4,286		6,445
One-time employee termination benefits	—		962		962		—		2,674		2,674
Total	$	2,482	$	5,936	$	8,418	$	21,437	$	9,717	$	31,154

The following table summarizes the activity related to the Company's restructuring liabilities for the six months ended September 30, 2023 (in thousands):

	One-Time Employee Termination Benefits		Contract Termination and Other Costs		Total
Accrued restructuring balance as of April 1, 2023	$	—	$	5,248	$	5,248
Costs incurred and charged to expense	2,674		22,035		24,709
Cash payments	(2,255)		(9,228)		(11,483)
Accrued restructuring balance as of September 30, 2023	$	419	$	18,055	$	18,474

The accrued restructuring balances as of September 30, 2023 represent estimated future cash payments required to satisfy the Company's remaining obligations, the majority of which are expected to be paid in the next twelve months.

16

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

10. OPERATING SEGMENT INFORMATION

The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income.

HPA is a leading global supplier of radio frequency ("RF") and power solutions for automotive, defense and aerospace, cellular infrastructure, broadband, industrial, enterprise and consumer markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and 5G and 6G network infrastructure.

CSG is a leading global supplier of connectivity and sensor solutions, with broad expertise spanning ultra-wideband, Matter®, Bluetooth® Low Energy, Zigbee®, Thread®, Wi-Fi®, cellular Internet of Things, microelectromechanical system-based sensors and bulk acoustic wave-based sensors. CSG’s markets include home and consumer electronics, industrial automation, automotive, smartphones, wearables, and industrial and enterprise access points.

ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies.

The "All other" category includes operating expenses such as stock-based compensation expense, amortization of intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill impairment, charges associated with a long-term capacity reservation agreement, fixed asset impairments, (loss) gain on sale of fixed assets and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

17

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Revenue:
HPA	$	149,804	$	228,132	$	289,496	$	439,083
CSG	103,622		143,329		202,885		295,644
ACG	850,067		786,596		1,262,276		1,458,688
Total revenue	$	1,103,493	$	1,158,057	$	1,754,657	$	2,193,415
Operating income (loss):
HPA	$	25,446	$	80,512	$	49,410	$	151,266
CSG	(27,725)		(10,019)		(47,886)		1,219
ACG	284,805		267,204		329,803		469,577
All other	(131,098)		(76,135)		(228,035)		(258,641)
Operating income	151,428		261,562		103,292		363,421
Interest expense	(17,121)		(16,904)		(34,382)		(34,156)
Other income (expense), net	5,211		2,214		18,927		(2,848)
Income before income taxes	$	139,518	$	246,872	$	87,837	$	326,417

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Reconciliation of "All other" category:
Stock-based compensation expense	$	(39,053)	$	(31,789)	$	(77,498)	$	(67,203)
Amortization of intangible assets	(29,963)		(32,787)		(60,835)		(66,439)
Restructuring-related charges (1)	(8,418)		(4,544)		(31,154)		(5,094)
Acquisition and integration-related costs	(852)		(8,642)		(2,047)		(14,950)
Goodwill impairment (2)	(48,000)		—		(48,000)		—
Charges associated with a long-term capacity reservation agreement	—		—		—		(110,000)
Other	(4,812)		1,627		(8,501)		5,045
Loss from operations for "All other"	$	(131,098)	$	(76,135)	$	(228,035)	$	(258,641)

(1) Refer to Note 9 for additional information.

(2) Refer to Note 3 for additional information.

11. INCOME TAXES

The Company’s income tax expense was $42.1 million and $34.0 million for the three and six months ended September 30, 2023, respectively, and income tax expense was $58.3 million and $68.9 million for the three and six months ended October 1, 2022, respectively. The Company’s effective tax rate was 30.1% and 38.7% for the three and six months ended September 30, 2023, respectively, and 23.6% and 21.1% for the three and six months ended October 1, 2022, respectively.

The Company's effective tax rate for the three and six months ended September 30, 2023 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, global intangible low tax income ("GILTI"), domestic tax credits generated, discrete tax items recorded during the period and the effects of a non-deductible goodwill impairment charge within the CSG segment. A discrete tax expense of $5.6 million and $5.5 million was recorded during the three and six months ended September 30, 2023 and primarily resulted from foreign currency gains recognized for tax purposes.

18

QORVO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

The Company's effective tax rate for the three and six months ended October 1, 2022 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, GILTI, domestic tax credits generated and discrete tax items recorded during the period. A discrete tax expense of $6.7 million and discrete tax benefit of $12.6 million was recorded during the three and six months ended October 1, 2022, respectively. The discrete tax expense for the three months ended October 1, 2022 primarily resulted from foreign currency gains recognized for tax purposes. The discrete tax benefit for the six months ended October 1, 2022 primarily resulted from certain charges associated with a long-term capacity reservation agreement recorded during the first quarter of fiscal 2023.

12. NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Numerator:
Numerator for basic and diluted net income per share — net income available to common stockholders	$	97,461	$	188,615	$	53,881	$	257,499
Denominator:
Denominator for basic net income per share — weighted-average shares	97,945		102,927		98,167		103,991
Effect of dilutive securities:
Stock-based awards	645		747		725		826
Denominator for diluted net income per share — adjusted weighted-average shares and assumed conversions	98,590		103,674		98,892		104,817
Basic net income per share	$	1.00	$	1.83	$	0.55	$	2.48
Diluted net income per share	$	0.99	$	1.82	$	0.54	$	2.46

In the computation of diluted net income per share for the three and six months ended September 30, 2023, approximately 0.8 million and 0.6 million shares, respectively, of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of diluted net income per share for the three and six months ended October 1, 2022, approximately 1.0 million and 0.7 million shares, respectively, of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive.

19

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions, and are not historical facts and typically are identified by terms such as "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "forecast," "predict," "potential," "continue" and similar words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements included herein represent management's current judgment and expectations, but our actual results, events and performance could differ materially from those expressed or implied by forward-looking statements. We do not intend to update any of these forward-looking statements or publicly announce the results of any revisions to these forward-looking statements, other than as is required under U.S. federal securities laws. Our business is subject to numerous risks and uncertainties, including those relating to fluctuations in our operating results on a quarterly and annual basis; our substantial dependence on developing new products and achieving design wins; our dependence on several large customers for a substantial portion of our revenue; a loss of revenue if defense and aerospace contracts are canceled or delayed; continued effects of the COVID-19 pandemic; our dependence on third parties; risks related to sales through distributors; risks associated with the operation of our manufacturing facilities; business disruptions; poor manufacturing yields; increased inventory risks and costs, including under long-term supply agreements, due to timing of customers' forecasts; our inability to effectively manage or maintain evolving relationships with chipset suppliers; our ability to continue to innovate in a very competitive industry; underutilization of manufacturing facilities; unfavorable changes in interest rates, pricing of certain precious metals, utility rates and foreign currency exchange rates; our acquisitions and other strategic investments failing to achieve financial or strategic objectives; our ability to attract, retain and motivate key employees; warranty claims, product recalls and product liability; changes in our effective tax rate; enactment of international or domestic tax legislation, or changes in regulatory guidance; changes in the favorable tax status of certain of our subsidiaries; risks associated with environmental, health and safety regulations, and climate change; risks from international sales and operations; economic regulation in China; changes in government trade policies, including imposition of tariffs and export restrictions; we may not be able to generate sufficient cash to service all of our debt; restrictions imposed by the agreements governing our debt; our reliance on our intellectual property portfolio; claims of infringement of third-party intellectual property rights; security breaches and other similar disruptions; theft, loss or misuse of personal data by or about our employees, customers or third parties; provisions in our governing documents and Delaware law may discourage takeovers and business combinations that our stockholders might consider to be in their best interests; and volatility in the price of our common stock. These and other risks and uncertainties, which are described in more detail under "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 1, 2023 and Qorvo's subsequent reports and statements that we file with the SEC, could cause actual results and developments to be materially different from those expressed or implied by any of these forward-looking statements.

20

Table of Contents

OVERVIEW

The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to help the reader understand the consolidated results of operations and financial condition of Qorvo, Inc. and Subsidiaries (together, the "Company" or "Qorvo"). MD&A is provided as a supplement to, and should be read in conjunction with, our Condensed Consolidated Financial Statements and accompanying Notes to Condensed Consolidated Financial Statements.

Qorvo® is a global leader in the development and commercialization of technologies and products for wireless, wired and power markets.

We design, develop, manufacture and market our products to U.S. and international original equipment manufacturers and original design manufacturers in three reportable operating segments: High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG"). Refer to Note 10 of the Notes to Condensed Consolidated Financial Statements for additional information regarding our reportable operating segments as of September 30, 2023.

HPA is a leading global supplier of radio frequency ("RF") and power solutions for automotive, defense and aerospace, cellular infrastructure, broadband, industrial, enterprise and consumer markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and 5G and 6G network infrastructure.

CSG is a leading global supplier of connectivity and sensor solutions, with broad expertise spanning ultra-wideband, Matter®, Bluetooth® Low Energy, Zigbee®, Thread®, Wi-Fi®, cellular Internet of Things, microelectromechanical system-based sensors and bulk acoustic wave ("BAW")-based sensors. CSG’s markets include home and consumer electronics, industrial automation, automotive, smartphones, wearables, and industrial and enterprise access points.

ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies.

SECOND QUARTER FISCAL 2024 FINANCIAL HIGHLIGHTS

•Revenue for the second quarter of fiscal 2024 decreased 4.7% as compared to the second quarter of fiscal 2023, primarily due to challenges in the global macroeconomic environment which negatively impacted end market demand for mass market smartphones and products in other markets including Wi-Fi, cellular infrastructure, power management and broadband. Revenue was also negatively impacted by ongoing efforts to reduce channel inventories. The decrease in revenue was partially offset by content gains at our largest end customer.

•Gross margin for the second quarter of fiscal 2024 decreased to 44.4% as compared to 46.5% for the second quarter of fiscal 2023, primarily due to average selling price erosion and the sell-through of inventory with higher unit costs resulting from lower production volumes, partially offset by lower inventory charges.

•Operating income was $151.4 million for the second quarter of fiscal 2024 as compared to operating income of $261.6 million for the second quarter of fiscal 2023. This decrease was primarily due to a goodwill impairment charge, lower revenue and lower gross margin. Refer to Note 3 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the goodwill impairment charge.

•Net income per diluted share was $0.99 for the second quarter of fiscal 2024 as compared to net income per diluted share of $1.82 for the second quarter of fiscal 2023.

•Capital expenditures were $28.6 million for the second quarter of fiscal 2024 as compared to $47.0 million for the second quarter of fiscal 2023.

21

Table of Contents

RESULTS OF OPERATIONS

Consolidated

The following tables present a summary of our results of operations (in thousands, except percentages): 

	Three Months Ended
	September 30, 2023		% of Revenue		October 1, 2022		% of Revenue		Increase (Decrease)		Percentage Change
Revenue	$	1,103,493	100.0	%	$	1,158,057	100.0	%	$	(54,564)	(4.7)	%
Cost of goods sold	613,803		55.6		619,130		53.5		(5,327)		(0.9)
Gross profit	489,690		44.4		538,927		46.5		(49,237)		(9.1)
Research and development	174,947		15.9		168,164		14.5		6,783		4.0
Selling, general and administrative	103,696		9.4		97,752		8.4		5,944		6.1
Other operating expense	59,619		5.4		11,449		1.0		48,170		420.7
Operating income	$	151,428	13.7	%	$	261,562	22.6	%	$	(110,134)	(42.1)	%
	Six Months Ended
	September 30, 2023		% of Revenue		October 1, 2022		% of Revenue		Increase (Decrease)		Percentage Change
Revenue	$	1,754,657	100.0	%	$	2,193,415	100.0	%	$	(438,758)	(20.0)	%
Cost of goods sold	1,035,897		59.0		1,279,238		58.3		(243,341)		(19.0)
Gross profit	718,760		41.0		914,177		41.7		(195,417)		(21.4)
Research and development	338,037		19.3		336,732		15.4		1,305		0.4
Selling, general and administrative	209,119		11.9		199,567		9.1		9,552		4.8
Other operating expense	68,312		3.9		14,457		0.6		53,855		372.5
Operating income	$	103,292	5.9	%	$	363,421	16.6	%	$	(260,129)	(71.6)	%

Revenue decreased for the three and six months ended September 30, 2023, compared to the three and six months ended October 1, 2022, primarily due to challenges in the global macroeconomic environment which negatively impacted end market demand for mass market smartphones and products in other markets including Wi-Fi, cellular infrastructure, power management and broadband. Revenue was also negatively impacted by ongoing efforts to reduce channel inventories. The decrease in revenue was partially offset by content gains at our largest end customer.

Gross margin decreased for the three months ended September 30, 2023, compared to the three months ended October 1, 2022, primarily due to average selling price erosion and the sell-through of inventory with higher unit costs resulting from lower production volumes, partially offset by lower inventory charges.

Gross margin decreased for the six months ended September 30, 2023, compared to the six months ended October 1, 2022, primarily due to the sell-through of inventory with higher unit costs resulting from lower production volumes, average selling price erosion and restructuring charges, partially offset by favorable changes in customer mix.

In fiscal 2022, we entered into a long-term capacity reservation agreement with a foundry supplier to purchase a certain number of wafers through calendar year 2025. In fiscal 2023, the agreement was amended and the term was extended through calendar year 2026. In the first quarter of fiscal 2023, we recorded charges of $110.0 million to "Cost of goods sold" based on our actual and estimated purchase shortfalls. No charges have been recorded to the Condensed Consolidated Statements of Income in the first quarter or second quarter of fiscal 2024 as a result of this agreement. In October 2023, the long-term capacity reservation agreement with the foundry supplier was further amended. Pursuant to the amendment, we are no longer obligated to order silicon wafers from the foundry supplier and the agreement will be terminated effective December 31, 2023. A contract termination fee of $65.0 million will be recorded to “Cost of goods sold” in the third quarter of fiscal 2024 and is expected to be paid during the fourth quarter of fiscal 2024.

22

Table of Contents

Operating expenses increased for the three and six months ended September 30, 2023, compared to the three and six months ended October 1, 2022, primarily due to a goodwill impairment charge, employee-related costs and restructuring charges. In addition, in fiscal 2024, we began a multiyear project to upgrade the core systems we use to run our business and recorded consulting expenses associated with this project.

Operating Segments

High Performance Analog

	Three Months Ended
(In thousands, except percentages)	September 30, 2023			October 1, 2022			Dollar Change		Percentage Change
Revenue	$	149,804		$	228,132		$	(78,328)	(34.3)	%
Operating income	25,446			80,512			(55,066)		(68.4)
Operating income as a % of revenue	17.0		%	35.3		%
	Six Months Ended
(In thousands, except percentages)	September 30, 2023			October 1, 2022			Dollar Change		Percentage Change
Revenue	$	289,496		$	439,083		$	(149,587)	(34.1)	%
Operating income	49,410			151,266			(101,856)		(67.3)
Operating income as a % of revenue	17.1		%	34.5		%

HPA revenue decreased for the three and six months ended September 30, 2023, compared to the three and six months ended October 1, 2022, primarily due to challenges in the global macroeconomic environment which negatively impacted end market demand for products in the cellular infrastructure, power management and broadband markets, including products supporting solid-state drives and power tools. Revenue was also negatively impacted by ongoing efforts to reduce channel inventories.

HPA operating income decreased for the three months ended September 30, 2023, compared to the three months ended October 1, 2022, primarily due to lower revenue and the sell-through of inventory with higher unit costs resulting from lower production volumes.

HPA operating income decreased for the six months ended September 30, 2023, compared to the six months ended October 1, 2022, primarily due to lower revenue, the sell-through of inventory with higher unit costs resulting from lower production volumes, and inventory-related charges.

23

Table of Contents

Connectivity and Sensors Group

	Three Months Ended
(In thousands, except percentages)	September 30, 2023			October 1, 2022			Dollar Change		Percentage Change
Revenue	$	103,622		$	143,329		$	(39,707)	(27.7)	%
Operating loss	(27,725)			(10,019)			(17,706)		(176.7)
Operating loss as a % of revenue	(26.8)		%	(7.0)		%
	Six Months Ended
(In thousands, except percentages)	September 30, 2023			October 1, 2022			Dollar Change		Percentage Change
Revenue	$	202,885		$	295,644		$	(92,759)	(31.4)	%
Operating (loss) income	(47,886)			1,219			(49,105)		(4,028.3)
Operating (loss) income as a % of revenue	(23.6)		%	0.4		%

CSG revenue decreased for the three and six months ended September 30, 2023, compared to the three and six months ended October 1, 2022, primarily due to challenges in the global macroeconomic environment which negatively impacted end market demand for Wi-Fi components. Revenue was also negatively impacted by ongoing efforts to reduce channel inventories.

CSG operating loss increased for the three months ended September 30, 2023, compared to the three months ended October 1, 2022, due to lower revenue and higher operating expenses driven by employee-related costs.

CSG operating income decreased for the six months ended September 30, 2023, compared to the six months ended October 1, 2022, primarily due to lower revenue, the sell-through of inventory with higher unit costs resulting from lower production volumes, average selling price erosion, and to a lesser extent, increased operating expenses primarily due to employee-related costs.

Advanced Cellular Group

	Three Months Ended
(In thousands, except percentages)	September 30, 2023			October 1, 2022			Dollar Change		Percentage Change
Revenue	$	850,067		$	786,596		$	63,471	8.1	%
Operating income	284,805			267,204			17,601		6.6
Operating income as a % of revenue	33.5		%	34.0		%
	Six Months Ended
(In thousands, except percentages)	September 30, 2023			October 1, 2022			Dollar Change		Percentage Change
Revenue	$	1,262,276		$	1,458,688		$	(196,412)	(13.5)	%
Operating income	329,803			469,577			(139,774)		(29.8)
Operating income as a % of revenue	26.1		%	32.2		%

ACG revenue increased for the three months ended September 30, 2023, compared to the three months ended October 1, 2022, primarily due to content gains at our largest end customer, partially offset by challenges in the global macroeconomic environment which negatively impacted end market demand for mass market smartphones. Revenue was also negatively impacted by ongoing efforts to reduce channel inventories.

ACG revenue decreased for the six months ended September 30, 2023, compared to the six months ended October 1, 2022, primarily due to challenges in the global macroeconomic environment which negatively impacted end market demand for mass

24

Table of Contents

market smartphones. Revenue was also negatively impacted by ongoing efforts to reduce channel inventories. The decrease in revenue was partially offset by content gains at our largest end customer.

ACG operating income increased for the three months ended September 30, 2023, compared to the three months ended October 1, 2022, primarily due to higher revenue, partially offset by average selling price erosion and higher product development costs.

ACG operating income decreased for the six months ended September 30, 2023, compared to the six months ended October 1, 2022, primarily due to lower revenue, average selling price erosion and the sell-through of inventory with higher unit costs resulting from lower production volumes. These decreases to operating income were partially offset by favorable changes in customer mix.

Refer to Note 10 of the Notes to Condensed Consolidated Financial Statements for a reconciliation of reportable segment operating income (loss) to the consolidated operating income for the three and six months ended September 30, 2023 and October 1, 2022.

INTEREST, OTHER INCOME (EXPENSE) AND INCOME TAXES

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Interest expense	$	(17,121)	$	(16,904)	$	(34,382)	$	(34,156)
Other income (expense), net	5,211		2,214		18,927		(2,848)
Income tax expense	(42,057)		(58,257)		(33,956)		(68,918)

Interest expense

During the three and six months ended September 30, 2023 and October 1, 2022, we recorded interest expense primarily related to our 1.750% senior notes due 2024 (the "2024 Notes"), our 4.375% senior notes due 2029 (the "2029 Notes") and our 3.375% senior notes due 2031 (the "2031 Notes"). Refer to Note 5 of the Notes to Condensed Consolidated Financial Statements for additional information.

Other income (expense), net

During the three months ended September 30, 2023, we recorded interest income of $7.7 million and net losses of $2.5 million from our share of the results from our limited partnership investments and other investments. During the six months ended September 30, 2023, we recorded interest income of $15.9 million and net gains of $2.1 million from our share of the results from our limited partnership investments and other investments.

During the three months ended October 1, 2022, we recorded interest income of $3.0 million and net losses of $0.7 million from our share of the results from our limited partnership investments and other investments. During the six months ended October 1, 2022, we recorded interest income of $4.7 million and net losses of $7.2 million from our share of the results from our limited partnership investments and other investments.

Refer to Note 4 of the Notes to Condensed Consolidated Financial Statements for additional information.

Income tax expense

During the three and six months ended September 30, 2023, we recorded income tax expense of $42.1 million and $34.0 million, respectively, comprised primarily of tax expense related to international operations generating pre-tax book income, the impact of global intangible low tax income ("GILTI") and discrete tax items, partially offset by tax benefits related to domestic and international operations generating pre-tax book losses and domestic tax credits recorded during the period. The discrete tax expense for the three and six months ended September 30, 2023 primarily resulted from foreign currency gains recognized for tax purposes.

During the three and six months ended October 1, 2022, we recorded income tax expense of $58.3 million and $68.9 million, respectively, comprised primarily of tax expense related to international operations generating pre-tax book income and the impact of GILTI, partially offset by tax benefits related to domestic and international operations generating pre-tax book losses,

25

Table of Contents

domestic tax credits generated and discrete tax items recorded during the period. The discrete tax expense for the three months ended October 1, 2022 primarily resulted from foreign currency gains recognized for tax purposes. The discrete tax benefit for the six months ended October 1, 2022 primarily resulted from certain charges associated with a long-term capacity reservation agreement recorded during the first quarter of fiscal 2023.

A valuation allowance remained against certain domestic and foreign net deferred tax assets as it is more likely than not that the related deferred tax assets will not be realized.

LIQUIDITY AND CAPITAL RESOURCES

Cash generated by operations is our primary source of liquidity. As of September 30, 2023, we had working capital of approximately $1,590.9 million, including $706.8 million in cash and cash equivalents, compared to working capital of approximately $1,474.0 million, including $808.8 million in cash and cash equivalents as of April 1, 2023.

Our $706.8 million of total cash and cash equivalents as of September 30, 2023, includes approximately $572.0 million held by our foreign subsidiaries, of which $358.8 million is held by Qorvo International Pte. Ltd. in Singapore. If the undistributed earnings of our foreign subsidiaries are needed in the U.S., we may be required to pay state income and/or foreign local withholding taxes to repatriate these earnings.

We may from time to time in the future seek to retire or make optional payments on our outstanding debt obligations through repurchases or exchanges of our outstanding notes, which may be effected through privately negotiated transactions, market transactions, tender offers, redemptions or otherwise. Such tenders, exchanges, purchases, or other transactions, if any, will be upon such terms and at such prices as we may determine, and will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.

Stock Repurchases

During the six months ended September 30, 2023, we repurchased approximately 2.0 million shares of our common stock for approximately $201.2 million (including transaction costs and excise tax) under our share repurchase program. As of September 30, 2023, approximately $1,505.0 million remains available for repurchases under the program.

Cash Flows from Operating Activities

Net cash provided by operating activities was $137.9 million and $540.4 million for the six months ended September 30, 2023 and October 1, 2022, respectively. This decrease in cash provided by operating activities was primarily due to decreased profitability and changes in working capital.

Cash Flows from Investing Activities

Net cash used in investing activities was $24.2 million and $84.3 million for the six months ended September 30, 2023 and October 1, 2022, respectively. During the six months ended September 30, 2023, we received proceeds of $47.3 million primarily from the sale of our BAW manufacturing facility in Farmers Branch, Texas.

Cash Flows from Financing Activities

Net cash used in financing activities was $214.3 million and $513.0 million for the six months ended September 30, 2023 and October 1, 2022, respectively, primarily due to our stock repurchases. Refer to Note 6 of the Notes to Condensed Consolidated Financial Statements for additional information regarding our stock repurchases.

COMMITMENTS AND CONTINGENCIES

Credit Agreement On September 29, 2020, we and certain of our U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "Credit Agreement") with Bank of America, N.A., acting as administrative agent, and a syndicate of lenders. The Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017. The Credit Agreement includes a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million, and included a senior term loan that was fully repaid in fiscal 2022. The Revolving Facility is available to finance working capital, capital expenditures and other general corporate purposes.

26

Table of Contents

Pursuant to the Credit Agreement, we may request one or more additional tranches of term loans or increases to the Revolving Facility, up to an aggregate of $500.0 million and subject to, among other things, securing additional funding commitments from the existing or new lenders.

On June 23, 2023, we entered into a second amendment to the Credit Agreement (the "Second Amendment"). The purpose of the Second Amendment was to amend certain covenants related to our ratio of Consolidated Funded Indebtedness to Consolidated EBITDA, as such terms are defined in the Credit Agreement (the "Consolidated Leverage Ratio"). The Second Amendment increases the maximum Consolidated Leverage Ratio to 4.00 to 1.00 for the fiscal quarters ended July 1, 2023 and September 30, 2023, and 3.50 to 1.00 for the fiscal quarters ending December 30, 2023 and March 30, 2024. For subsequent fiscal quarters, the maximum Consolidated Leverage Ratio will return to 3.00 to 1.00.

During the six months ended September 30, 2023, there were no borrowings under the Revolving Facility.

The Credit Agreement contains various conditions, covenants and representations with which we must be in compliance in order to borrow funds and to avoid an event of default. As of September 30, 2023, we were in compliance with these covenants.

2024 Notes On December 14, 2021, we issued $500.0 million aggregate principal amount of our 2024 Notes. Interest on the 2024 Notes is payable on June 15 and December 15 of each year at a rate of 1.750% per annum. The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

2029 Notes On September 30, 2019, we issued $350.0 million aggregate principal amount of our 2029 Notes. On December 20, 2019, and June 11, 2020, we issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of our 2029 Notes. Interest on the 2029 Notes is payable on April 15 and October 15 of each year at a rate of 4.375% per annum. The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

2031 Notes On September 29, 2020, we issued $700.0 million aggregate principal amount of our 2031 Notes. Interest on the 2031 Notes is payable on April 1 and October 1 of each year at a rate of 3.375% per annum. The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

For additional information regarding our long-term debt, refer to Note 5 of the Notes to Condensed Consolidated Financial Statements.

Capital Commitments As of September 30, 2023, we had capital commitments of approximately $65.7 million primarily for expanding capability to support new products, equipment and facility upgrades and cost savings initiatives.

Future Sources of Funding Our future capital requirements may differ materially from those currently projected and will depend on many factors, including market acceptance of, and demand for, our products, acquisition opportunities, technological advances and our relationships with suppliers and customers. Based on current and projected levels of cash flows from operations, coupled with our existing cash, cash equivalents and our Revolving Facility, we believe we have sufficient liquidity to meet both our short-term and long-term cash requirements. However, if there is a significant decrease in demand for our products, or if our demand grows faster than we anticipate, operating cash flows may be insufficient to meet our needs. If existing resources and cash from operations are not sufficient to meet our future requirements or if we perceive conditions to be favorable, we may seek additional debt or equity financing. Additional debt or equity financing could be dilutive to holders of our common stock. Further, we cannot be sure that any additional debt or equity financing, if required, will be available on favorable terms, if at all.

Legal We are involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. We accrue a liability for legal contingencies when we believe that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. We regularly evaluate developments in our legal matters that could affect the amount of the previously accrued liability and record adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters

27

Table of Contents

will not, individually or in the aggregate, have a material adverse effect on our consolidated financial position or results of operations. We believe the aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

Taxes We are subject to income and other taxes in the United States and in numerous foreign jurisdictions. Our domestic and foreign tax liabilities are subject to the allocation of revenue and expenses in different jurisdictions. Additionally, the amount of taxes paid is subject to our interpretation of applicable tax laws in the jurisdictions in which we operate. We are subject to audits by tax authorities. While we endeavor to comply with all applicable tax laws, there can be no assurance that a governing tax authority will not have a different interpretation of the law than we do or that we will comply in all respects with applicable tax laws, which could result in additional taxes. There can be no assurance that the outcomes from tax audits will not have an adverse effect on our results of operations in the period during which the review is conducted.

SUPPLEMENTAL PARENT AND GUARANTOR FINANCIAL INFORMATION

In accordance with the indentures governing the 2024 Notes, the 2029 Notes and the 2031 Notes (together, the "Notes"), our obligations under the Notes are fully and unconditionally guaranteed on a joint and several unsecured basis by the Guarantors, which are listed on Exhibit 22 to this Quarterly Report on Form 10-Q. Each Guarantor is 100% owned, directly or indirectly, by Qorvo, Inc. ("Parent"). A Guarantor can be released in certain customary circumstances. Our other U.S. subsidiaries and our non-U.S. subsidiaries do not guarantee the Notes (such subsidiaries are referred to as the "Non-Guarantors").

The following presents summarized financial information for the Parent and the Guarantors on a combined basis as of and for the periods indicated, after eliminating (i) intercompany transactions and balances among the Parent and the Guarantors, and (ii) equity earnings from, and investments in, any Non-Guarantor. The summarized financial information may not necessarily be indicative of the financial position and results of operations had the combined Parent and Guarantors operated independently from the Non-Guarantors.

Summarized Balance Sheets (in thousands)	September 30, 2023		April 1, 2023
ASSETS
Current assets (1)	$	829,203	$	972,989
Non-current assets	2,272,426		2,398,287
LIABILITIES
Current liabilities	$	259,834	$	296,049
Long-term liabilities (2)	2,725,696		2,689,824

(1) Includes net amounts due from Non-Guarantor subsidiaries of $292.8 million and $379.5 million as of September 30, 2023 and April 1, 2023, respectively.

(2) Includes net amounts due to Non-Guarantor subsidiaries of $568.9 million and $509.1 million as of September 30, 2023 and April 1, 2023, respectively.

Summarized Statement of Operations	Six Months Ended
(in thousands)	September 30, 2023
Revenue	$	500,482
Gross profit	82,354
Net loss	(158,151)

28

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

There have been no material changes to our market risk exposures during the second quarter of fiscal 2024. For a discussion of our exposure to market risk, refer to Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," contained in Qorvo's Annual Report on Form 10-K for the fiscal year ended April 1, 2023.

ITEM 4. CONTROLS AND PROCEDURES.

As of the end of the period covered by this report, the Company’s management, with the participation of the Company’s Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), evaluated the effectiveness of the Company’s disclosure controls and procedures in accordance with Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our CEO and CFO concluded that the Company’s disclosure controls and procedures were effective, as of such date, to enable the Company to record, process, summarize and report in a timely manner the information that the Company is required to disclose in its Exchange Act reports, and to accumulate and communicate such information to management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

29

Table of Contents

PART II — OTHER INFORMATION

ITEM 1A. RISK FACTORS.

In addition to the other information set forth in this report and in our other reports and statements that we file with the United States Securities and Exchange Commission ("SEC"), careful consideration should be given to the factors discussed in Part I, Item 1A., "Risk Factors" in Qorvo's Annual Report on Form 10-K for the fiscal year ended April 1, 2023, which could materially affect our business, financial condition or future results. The risks described in Qorvo's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES.

(c) Issuer Purchases of Equity Securities

Period	Total number of shares purchased (in thousands)	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs (in thousands)	Approximate dollar value of shares that may yet be purchased under the plans or programs (in millions)
July 2, 2023 to July 29, 2023	147	$	103.93	147	$	1,589.7
July 30, 2023 to August 26, 2023	153	103.97		153	1,573.8
August 27, 2023 to September 30, 2023	669	102.94		669	1,505.0
Total	969	$	103.26	969

On November 2, 2022, we announced that our Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of our outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization. Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which we repurchase our shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require us to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended, or terminated at any time without prior notice.

As of January 1, 2023, our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. The excise tax is recognized as part of the cost basis of shares acquired in the Condensed Consolidated Statements of Stockholders' Equity and is excluded from amounts presented above.

30

Table of Contents

ITEM 5. OTHER INFORMATION.

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

The following table describes actions by our directors and Section 16 officers with respect to plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) during the second quarter of fiscal 2024. None of our directors or Section 16 officers took actions with respect to a "non-Rule 10b5-1 trading arrangement," as such term is defined in Item 408(c) of Regulation S-K, during the second quarter of fiscal 2024.

Name and Title	Action	Date	Expiration of Plan	Number of Shares to be Sold(1)
Philip J. Chesley Senior Vice President and President of High Performance Analog	Adoption	8/25/2023	8/30/2024	27,898

(1) Represents the gross number of shares subject to the Rule 10b5-1 plan, excluding the potential effect of shares withheld for taxes. Amounts may include shares to be earned as performance-based restricted stock unit awards ("PBRSUs") and are presented at their target amounts. The actual number of PBRSUs earned following the end of the applicable performance period, if any, will depend on the relative attainment of the performance metrics.

31

Table of Contents

ITEM 6. EXHIBITS.

 

22	List of Subsidiary Guarantors
31.1	Certification of Periodic Report by Robert A. Bruggeworth, as Chief Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Periodic Report by Grant A. Brown, as Chief Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Periodic Report by Robert A. Bruggeworth, as Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Periodic Report by Grant A. Brown, as Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	The following materials from our Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Income; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders' Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements
104	The cover page from our Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in iXBRL

Our SEC file number for documents filed with the SEC pursuant to the Securities Exchange Act of 1934, as amended, is 001-36801.

32

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Qorvo, Inc.
Date:	November 2, 2023	/s/ Grant A. Brown
		Grant A. Brown
		Senior Vice President and Chief Financial Officer

33

EX-22

Exhibit 22

List of Subsidiary Guarantors

The 1.750% Senior Notes due 2024, the 4.375% Senior Notes due 2029 and the 3.375% Senior Notes due 2031 are guaranteed, jointly and severally, on an unsecured basis, by the following 100% owned subsidiaries of Qorvo, Inc., a Delaware corporation, as of September 30, 2023:

Entity	Jurisdiction of Incorporation or Organization
Amalfi Semiconductor, Inc.	Delaware
RFMD, LLC	North Carolina
Qorvo California, Inc.	California
Qorvo US, Inc.	Delaware
Qorvo Texas, LLC	Texas
Qorvo Oregon, Inc.	Oregon

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE EXCHANGE ACT, AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert A. Bruggeworth, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Qorvo, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

    Date: November 2, 2023

/s/ ROBERT A. BRUGGEWORTH

Robert A. Bruggeworth

President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE EXCHANGE ACT, AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Grant A. Brown, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of Qorvo, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

    Date: November 2, 2023

/s/ GRANT A. BROWN

Grant A. Brown

Senior Vice President and Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert A. Bruggeworth, President and Chief Executive Officer of Qorvo, Inc. (the “Company”), certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to my knowledge:

(1)    the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended September 30, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ ROBERT A. BRUGGEWORTH

    Robert A. Bruggeworth

    President and Chief Executive Officer

November 2, 2023

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Grant A. Brown, Senior Vice President and Chief Financial Officer of Qorvo, Inc. (the “Company”), certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to my knowledge:

(1)    the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended September 30, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ GRANT A. BROWN

    Grant A. Brown

    Senior Vice President and Chief Financial Officer

November 2, 2023

XML

Cover Page - shares	6 Months Ended
	Sep. 30, 2023	Oct. 26, 2023
Cover [Abstract]
Document Transition Report	false
Document Quarterly Report	true
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Current Reporting Status	Yes
Entity Incorporation, State or Country Code	DE
Entity Registrant Name	Qorvo, Inc.
City Area Code	336
Entity Central Index Key	0001604778
Document Type	10-Q
Document Period End Date	Sep. 30, 2023
Entity File Number	001-36801
Amendment Flag	false
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--03-30
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding		97,345,755
Entity Address, Address Line One	7628 Thorndike Road
Local Phone Number	664-1233
Entity Interactive Data Current	Yes
Entity Shell Company	false
Trading Symbol	QRVO
Security Exchange Name	NASDAQ
Entity Tax Identification Number	46-5288992
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27409-9421
Document Fiscal Year Focus	2024

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Apr. 01, 2023
Current assets:
Cash and cash equivalents	$ 706,836	$ 808,757
Accounts receivable, net of allowance of $494 and $369 as of September 30, 2023 and April 1, 2023, respectively	592,738	304,519
Inventories	839,855	796,596
Prepaid expenses	49,120	46,684
Other Receivables, Net, Current	27,888	26,535
Other current assets	46,440	46,703
Total current assets	2,262,877	2,029,794
Property and equipment, net of accumulated depreciation of $1,976,429 and $1,900,317 as of September 30, 2023 and April 1, 2023, respectively	1,061,163	1,149,806
Goodwill	2,708,310	2,760,813
Intangible assets, net	473,164	537,703
Long-term investments	25,649	20,406
Other non-current assets	187,357	193,381
Total assets	6,718,520	6,691,903
Current liabilities:
Accounts payable	275,256	210,701
Accrued liabilities	303,810	222,463
Other current liabilities	92,876	122,599
Total current liabilities	671,942	555,763
Long-Term Debt, Excluding Current Maturities	2,048,585	2,048,073
Other long-term liabilities	180,807	185,273
Total liabilities	2,901,334	2,789,109
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 97,506 and 98,649 shares issued and outstanding at September 30, 2023 and April 1, 2023, respectively	3,796,189	3,821,474
Accumulated other comprehensive loss	(13,609)	(3,175)
Retained earnings	34,606	84,495
Total stockholders’ equity	3,817,186	3,902,794
Total liabilities and stockholders’ equity	$ 6,718,520	$ 6,691,903

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Apr. 01, 2023
Statement of Financial Position [Abstract]
Common stock, shares outstanding	97,506,000	98,649,000
Accounts Receivable, Allowance for Credit Loss, Current	$ 494	$ 369
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 1,976,429	$ 1,900,317
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, par value	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	405,000,000	405,000,000
Common Stock, Shares, Issued	97,506,000	98,649,000

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Income Statement [Abstract]
Revenues	$ 1,103,493	$ 1,158,057	$ 1,754,657	$ 2,193,415
Cost of goods sold	613,803	619,130	1,035,897	1,279,238
Gross profit	489,690	538,927	718,760	914,177
Operating Expenses [Abstract]
Research and Development Expense	174,947	168,164	338,037	336,732
Selling, general and administrative	103,696	97,752	209,119	199,567
Other operating expense	59,619	11,449	68,312	14,457
Total operating expenses	338,262	277,365	615,468	550,756
Operating (loss) income	151,428	261,562	103,292	363,421
Interest expense	(17,121)	(16,904)	(34,382)	(34,156)
Other income (expense), net	5,211	2,214	18,927	(2,848)
Income before income taxes	139,518	246,872	87,837	326,417
Income tax benefit (expense)	(42,057)	(58,257)	(33,956)	(68,918)
Net income	$ 97,461	$ 188,615	$ 53,881	$ 257,499
Earnings Per Share [Abstract]
Basic	$ 1.00	$ 1.83	$ 0.55	$ 2.48
Diluted	$ 0.99	$ 1.82	$ 0.54	$ 2.46
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic	97,945	102,927	98,167	103,991
Diluted	98,590	103,674	98,892	104,817

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 97,461	$ 188,615	$ 53,881	$ 257,499
Other comprehensive loss, net of tax:
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature	(9,569)	(23,811)	(10,428)	(47,026)
Reclassification adjustments, net of tax:
Amortization of pension actuarial (gain) loss	(3)	9	(6)	18
Other comprehensive loss	(9,572)	(23,802)	(10,434)	(47,008)
Total comprehensive income	$ 87,889	$ 164,813	$ 43,447	$ 210,491

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive Loss	Retained Earnings [Member]
Common Stock, Shares, Outstanding		106,303
Common stock and additional paid-in capital	$ 4,035,849
Stockholders' Equity Attributable to Parent	4,553,218
Accumulated Other Comprehensive Income (Loss), Net of Tax	5,232
Retained Earnings (Accumulated Deficit)	512,137
Net income	257,499	$ 0	$ 0	$ 257,499
Other Comprehensive Income (Loss), Net of Tax	(47,008)	$ 0	(47,008)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		509
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(21,181)	$ (21,181)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		195
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 18,893	$ 18,893	0	0
Stock Repurchased During Period, Shares	(4,900)	(4,946)
Stock Repurchased During Period, Value	$ (510,099)	$ (188,410)	0	(321,689)
Stock-based compensation	70,818	$ 70,818	0	0
Payments for Repurchase of Common Stock	510,099
Common Stock, Shares, Outstanding		103,340
Common stock and additional paid-in capital	3,962,499
Stockholders' Equity Attributable to Parent	4,300,605
Accumulated Other Comprehensive Income (Loss), Net of Tax	(17,974)
Retained Earnings (Accumulated Deficit)	356,080
Net income	188,615	$ 0	0	188,615
Other Comprehensive Income (Loss), Net of Tax	(23,802)	$ 0	(23,802)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		372
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	$ (16,993)	$ (16,993)	0	0
Stock Repurchased During Period, Shares	(1,700)	(1,651)
Stock Repurchased During Period, Value	$ (160,057)	$ (63,309)	0	(96,748)
Stock-based compensation	$ 33,772	$ 33,772	0	0
Common Stock, Shares, Outstanding	102,061	102,061
Common stock and additional paid-in capital	$ 3,915,969
Stockholders' Equity Attributable to Parent	4,322,140
Accumulated Other Comprehensive Income (Loss), Net of Tax	(41,776)
Retained Earnings (Accumulated Deficit)	$ 447,947
Common Stock, Shares, Outstanding	98,649
Common stock and additional paid-in capital	$ 3,821,474
Stockholders' Equity Attributable to Parent	3,902,794
Accumulated Other Comprehensive Income (Loss), Net of Tax	(3,175)
Retained Earnings (Accumulated Deficit)	84,495
Net income	53,881	$ 0	0	53,881
Other Comprehensive Income (Loss), Net of Tax	(10,434)	$ 0	(10,434)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		597
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(24,163)	$ (24,163)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		262
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 19,180	$ 19,180	0	0
Stock Repurchased During Period, Shares	(2,000)	(2,002)
Stock Repurchased During Period, Value	$ (201,166)	$ (97,396)	0	(103,770)
Stock-based compensation	77,094	$ 77,094	0	0
Payments for Repurchase of Common Stock	200,026
Common Stock, Shares, Outstanding		98,048
Common stock and additional paid-in capital	3,816,260
Stockholders' Equity Attributable to Parent	3,812,223
Accumulated Other Comprehensive Income (Loss), Net of Tax	(4,037)
Retained Earnings (Accumulated Deficit)	0
Net income	97,461	$ 0	0	97,461
Other Comprehensive Income (Loss), Net of Tax	(9,572)	$ 0	(9,572)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		427
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	$ (19,741)	$ (19,741)	0	0
Stock Repurchased During Period, Shares	(1,000)	(969)
Stock Repurchased During Period, Value	$ (100,554)	$ (37,699)	0	(62,855)
Stock-based compensation	$ 37,369	$ 37,369	$ 0	$ 0
Common Stock, Shares, Outstanding	97,506
Common stock and additional paid-in capital	$ 3,796,189
Stockholders' Equity Attributable to Parent	3,817,186
Accumulated Other Comprehensive Income (Loss), Net of Tax	(13,609)
Retained Earnings (Accumulated Deficit)	$ 34,606

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022
Cash flows from operating activities:
Net income	$ 53,881	$ 257,499
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	99,183	103,882
Intangible assets amortization	61,103	66,539
Deferred income taxes	1,629	(16,693)
Stock-based compensation expense	77,498	67,203
Other, net	64,377	58,804
Changes in operating assets and liabilities:
Accounts receivable, net	(288,221)	(75,728)
Inventories	(45,694)	(81,716)
Prepaid expenses and other assets	(2,547)	30,503
Accounts payable and accrued liabilities	148,616	65,012
Income taxes payable and receivable	(9,674)	3,518
Other liabilities	(22,253)	61,601
Net cash provided by operating activities	137,898	540,424
Cash flows from investing activities:
Purchase of property and equipment	(68,076)	(90,454)
Proceeds from Sale of Property, Plant, and Equipment	47,301	331
Other investing activities	(3,418)	5,841
Net cash used in investing activities	(24,193)	(84,282)
Cash flows from financing activities:
Repurchase of common stock, including transaction costs	(200,026)	(510,099)
Proceeds from the issuance of common stock	21,041	19,541
Tax withholding paid on behalf of employees for restricted stock units	(25,472)	(22,020)
Other financing activities	(9,854)	(379)
Net cash used in financing activities	(214,311)	(512,957)
Net decrease in cash, cash equivalents and restricted cash	(102,107)	(61,052)
Cash, cash equivalents and restricted cash at the beginning of the period	808,943	972,805
Cash, cash equivalents and restricted cash at the end of the period	706,836	911,753
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,501)	(4,237)
Cash and cash equivalents	706,836	911,570
Restricted cash included in "Other current assets" and "Other non-current assets"	0	183
Capital expenditures included in liabilities	$ 27,610	$ 26,658

XML

Basis of Presentation and Significant Accounting Policies

6 Months Ended

Sep. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying Condensed Consolidated Financial Statements of Qorvo, Inc. and Subsidiaries (together, the "Company" or "Qorvo") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). The preparation of these financial statements requires management to make estimates and assumptions, which could differ materially from actual results. In addition, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the United States Securities and Exchange Commission (the "SEC"). In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. These Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended April 1, 2023.

The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company operates under three segments, High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG").

Certain prior period amounts have been reclassified to conform to the fiscal 2024 presentation.

The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. Each fiscal year, the first quarter ends on the Saturday closest to June 30, the second quarter ends on the Saturday closest to September 30 and the third quarter ends on the Saturday closest to December 31. Fiscal years 2024 and 2023 are 52-week years.

XML

Inventories

6 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

The components of inventories, net of reserves, are as follows (in thousands):

	September 30, 2023		April 1, 2023
Raw materials	$	266,354	$	264,367
Work in process	421,295		345,545
Finished goods	152,206		186,684
Total inventories	$	839,855	$	796,596

XML

Goodwill and Intangible Assets

6 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill are as follows (in thousands):

	HPA		CSG		ACG		Total
Balance as of April 1, 2023 (1)	$	501,602	$	525,351	$	1,733,860	$	2,760,813
Goodwill impairment	—		(48,000)		—		(48,000)
Effect of changes in foreign currency exchange rates	—		(4,503)		—		(4,503)
Balance as of September 30, 2023 (1)	$	501,602	$	472,848	$	1,733,860	$	2,708,310

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $730.0 million and $682.0 million as of September 30, 2023 and April 1, 2023, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023 and 2024.

During the second quarter of fiscal 2024, the Company completed an interim test for goodwill impairment as management determined, based on revisions to long-term forecasts, it was more likely than not that the fair value of a reporting unit within the CSG segment was below its carrying amount. The quantitative analysis, which considered the income approach and the market approach to estimate the reporting unit's fair value, resulted in a goodwill impairment charge of approximately $48.0 million, which was recorded in "Other operating expense" in the Condensed Consolidated Statements of Income.

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):

	September 30, 2023				April 1, 2023
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	863,836	$	430,265	$	872,106	$	382,448
Customer relationships	87,040		58,551		104,616		67,485
Technology licenses	2,224		703		1,664		513
Trade names	910		901		910		789
In-process research and development	9,574		N/A		9,642		N/A
Total (1)	$	963,584	$	490,420	$	988,938	$	451,235

(1) Amounts include the impact of foreign currency translation.

At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets.

XML

Investments and Fair Value of Financial Instruments

3 Months Ended

Sep. 30, 2023

Investments and Fair Value Measurements [Abstract]

Investments and Fair Value Measurements [Text Block]

INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS

Equity Method Investments

The Company invests in limited partnerships and accounts for these investments using the equity method. The carrying amounts of these investments, as of September 30, 2023 and April 1, 2023 were $18.5 million and $20.4 million, respectively, and are classified as "Long-term investments" in the Condensed Consolidated Balance Sheets. During the three and six months ended September 30, 2023, the Company recorded a loss of $1.2 million and income of $0.9 million, respectively, based on its share of the limited partnerships' results. During the three and six months ended October 1, 2022, the Company recorded income of $1.2 million and $0.4 million, respectively, based on its share of the limited partnerships' results. These amounts are included in "Other income (expense), net" in the Condensed Consolidated Statements of Income. During the three and six months ended September 30, 2023, the Company received cash distributions of $2.3 million and $2.8 million, respectively, from these limited partnerships. No cash distributions were received during the three months ended October 1, 2022 and $2.0 million of cash distributions were received during the six months ended October 1, 2022. The cash distributions were recognized as reductions to the carrying value of the investments and included in the cash flows from investing activities in the Condensed Consolidated Statements of Cash Flows.

Fair Value of Financial Instruments

The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands):

	Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
September 30, 2023
Marketable equity securities	$	642	$	642	$	—	$	—
Invested funds in deferred compensation plan (1)	42,939		42,939		—		—
April 1, 2023
Marketable equity securities	$	1,094	$	1,094	$	—	$	—
Invested funds in deferred compensation plan (1)	40,653		40,653		—		—
Contingent earn-out liability (2)	(31,250)		—		—		(31,250)

(1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments.

(2) The fair value of the contingent consideration liability which related to the acquisition of United Silicon Carbide, Inc. was equal to the maximum amount payable at April 1, 2023 and was subsequently paid in the first quarter of fiscal 2024.

XML

Long-Term Debt

3 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

DEBT

LONG-TERM DEBT

Long-term debt is as follows (in thousands):

	September 30, 2023		April 1, 2023
1.750% senior notes due 2024	$	500,000	$	500,000
4.375% senior notes due 2029	850,000		850,000
3.375% senior notes due 2031	700,000		700,000
Finance leases and other	1,238		1,666
Unamortized premium, discount and issuance costs, net	(2,557)		(3,283)
Less current portion of long-term debt	(96)		(310)
Total long-term debt	$	2,048,585	$	2,048,073

Credit Agreement

On September 29, 2020, the Company and certain of its U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "Credit Agreement") with Bank of America, N.A., acting as administrative agent, and a syndicate of lenders. The Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017. The Credit Agreement includes a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million, and included a senior term loan that was fully repaid in fiscal 2022. The Revolving Facility is available to finance working capital, capital expenditures and other general corporate purposes.

Pursuant to the Credit Agreement, the Company may request one or more additional tranches of term loans or increases to the Revolving Facility, up to an aggregate of $500.0 million and subject to, among other things, securing additional funding commitments from the existing or new lenders.

On April 6, 2022, the Company and the administrative agent entered into an amendment to the Credit Agreement (the "LIBOR Transition Amendment") to replace the London Interbank Offered Rate as a reference rate available for use in the computation of interest under the Credit Agreement. As a result of the LIBOR Transition Amendment, at the Company’s option, loans

under the Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus the Term SOFR (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate as set by the administrative agent, and (c) the Term SOFR plus 1.0% (the "Base Rate"). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Term SOFR is the rate per annum equal to the forward-looking Secured Overnight Financing Rate term rate for interest periods of one, three or six months (as selected by the Company) plus an adjustment (as defined in the Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.250% per annum, and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.250% per annum. Undrawn amounts under the Revolving Facility are subject to a commitment fee ranging from 0.150% to 0.200%.

On June 23, 2023, the Company entered into a second amendment to the Credit Agreement (the "Second Amendment"). The purpose of the Second Amendment was to amend certain covenants related to the Company’s ratio of Consolidated Funded Indebtedness to Consolidated EBITDA, as such terms are defined in the Credit Agreement (the "Consolidated Leverage Ratio"). The Second Amendment increased the maximum Consolidated Leverage Ratio to 4.00 to 1.00 for the fiscal quarters ended July 1, 2023 and September 30, 2023, and 3.50 to 1.00 for the fiscal quarters ending December 30, 2023 and March 30, 2024. For subsequent fiscal quarters, the maximum Consolidated Leverage Ratio will return to 3.00 to 1.00.

During the three and six months ended September 30, 2023, there were no borrowings under the Revolving Facility.

The Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and to avoid an event of default. As of September 30, 2023, the Company was in compliance with these covenants.

Senior Notes due 2024

On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The 2024 Notes were issued pursuant to an indenture, dated as of December 14, 2021 (the "2021 Indenture"), by and among the Company, the Guarantors and Computershare Trust Company, N.A., as trustee. The 2021 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants.

In connection with the offering of the 2024 Notes, the Company entered into a Registration Rights Agreement, dated as of December 14, 2021 (the "Registration Rights Agreement"), by and among the Company and the Guarantors, on the one hand, and BofA Securities, Inc., as representative of the initial purchasers of the 2024 Notes, on the other hand.

On September 13, 2023, pursuant to their obligations under the Registration Rights Agreement, the Company and the Guarantors filed with the SEC a registration statement relating to the registered exchange offer (the "Exchange Offer") to exchange the 2024 Notes for a new series of the Company's exchange notes having terms substantially identical in all material respects to, and in the same aggregate principal amount as, the 2024 Notes. On October 16, 2023, the Company and the Guarantors commenced the Exchange Offer, which is scheduled to expire on November 17, 2023, unless extended.

Interest is payable on the 2024 Notes on June 15 and December 15 of each year. The Company paid no interest on the 2024 Notes during the three months ended September 30, 2023 and October 1, 2022, and paid interest of $4.4 million during both the six months ended September 30, 2023 and October 1, 2022.

Senior Notes due 2029

On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and collectively with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in

accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019, and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture.

Interest is payable on the 2029 Notes on April 15 and October 15 of each year. The Company paid no interest on the 2029 Notes during the three months ended September 30, 2023 and October 1, 2022, and paid interest of $18.6 million during both the six months ended September 30, 2023 and October 1, 2022.

Senior Notes due 2031

On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture.

Interest is payable on the 2031 Notes on April 1 and October 1 of each year. The Company paid no interest on the 2031 Notes during the three and six months ended September 30, 2023, and paid interest of $11.8 million during the three and six months ended October 1, 2022.

Fair Value of Long-Term Debt

The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of September 30, 2023 was $470.7 million, $751.1 million and $553.8 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 1, 2023 was $464.2 million, $785.9 million and $565.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

Interest Expense

During the three and six months ended September 30, 2023, the Company recognized $17.9 million and $36.1 million of interest expense, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $0.8 million and $1.7 million, respectively. During the three and six months ended October 1, 2022, the Company recognized $17.9 million and $36.1 million of interest expense, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $1.0 million and $2.0 million, respectively.

XML

Stock Repurchases

6 Months Ended

Sep. 30, 2023

Equity [Abstract]

STOCK REPURCHASES

STOCK REPURCHASES

On November 2, 2022, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization.

Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended, or terminated at any time without prior notice. As of January 1, 2023, the Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. The excise tax is recognized as part of the cost basis of shares acquired in the Condensed Consolidated Statements of Stockholders' Equity.

During the three and six months ended September 30, 2023, the Company repurchased approximately 1.0 million and 2.0 million shares of its common stock, respectively, for approximately $100.6 million and $201.2 million, respectively (including transaction costs and excise tax) under the current share repurchase program. As of September 30, 2023, approximately $1,505.0 million remains available for repurchases under the current share repurchase program.

During the three and six months ended October 1, 2022, the Company repurchased approximately 1.7 million and 4.9 million shares, respectively, of its common stock for approximately $160.1 million and $510.1 million, respectively (including transaction costs) under the prior share repurchase program.

XML

Commitments and Contingent Liabilities

6 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

COMMITMENTS AND CONTINGENT LIABILITIES

In fiscal 2022, the Company entered into a long-term capacity reservation agreement with a foundry supplier to purchase a certain number of wafers through calendar year 2025. In fiscal 2023, the agreement was amended and the term was extended through calendar year 2026. In the first quarter of fiscal 2023, the Company recorded charges of $110.0 million to "Cost of goods sold" based on the actual and estimated purchase shortfalls. No charges have been recorded to the Condensed Consolidated Statements of Income in the first quarter or second quarter of fiscal 2024 as a result of this agreement.

In October 2023, the long-term capacity reservation agreement with the foundry supplier was further amended. Pursuant to the amendment, the Company is no longer obligated to order silicon wafers from the foundry supplier and the agreement will be terminated effective December 31, 2023. A contract termination fee of $65.0 million will be recorded to “Cost of goods sold” in the third quarter of fiscal 2024 and is expected to be paid by the Company during the fourth quarter of fiscal 2024.

Legal Matters

The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

XML

Revenue

6 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

REVENUE

REVENUE

Revenue to customers by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
United States	$	699,288	$	615,007	$	1,014,571	$	1,011,038
China	189,900		221,737		340,706		505,213
Other Asia	119,395		126,360		210,729		318,688
Taiwan	66,162		130,463		132,018		221,635
Europe	28,748		64,490		56,633		136,841
Total revenue	$	1,103,493	$	1,158,057	$	1,754,657	$	2,193,415

The Company also disaggregates revenue by operating segments (refer to Note 10).

XML

Restructuring and Related Activities

6 Months Ended

Sep. 30, 2023

Restructuring and Related Activities [Abstract]

RESTRUCTURING

RESTRUCTURING

During fiscal 2023, the Company initiated actions to improve efficiencies in its operations and further align the organization with its strategic objectives. These initiatives included seeking strategic alternatives related to its non-core biotechnology business. In the second quarter of fiscal 2024, it was determined that this business met the held for sale criteria under ASC 360, "Property, Plant and Equipment," and the sale of this business was subsequently completed in October 2023.

The Company will continue to evaluate its operating footprint, cost structure and strategic opportunities, but does not expect to incur additional material charges related to its 2023 restructuring initiatives. The restructuring charges recorded by the Company are not allocated to its reportable segments.

The following table summarizes the charges resulting from restructuring initiatives (in thousands):

	Three Months Ended September 30, 2023						Six Months Ended September 30, 2023
	Cost of Goods Sold		Other Operating Expense		Total		Cost of Goods Sold		Other Operating Expense		Total
Contract termination and other costs	$	2,482	$	1,328	$	3,810	$	19,278	$	2,757	$	22,035
Asset impairment costs	—		3,646		3,646		2,159		4,286		6,445
One-time employee termination benefits	—		962		962		—		2,674		2,674
Total	$	2,482	$	5,936	$	8,418	$	21,437	$	9,717	$	31,154

The following table summarizes the activity related to the Company's restructuring liabilities for the six months ended September 30, 2023 (in thousands):

	One-Time Employee Termination Benefits		Contract Termination and Other Costs		Total
Accrued restructuring balance as of April 1, 2023	$	—	$	5,248	$	5,248
Costs incurred and charged to expense	2,674		22,035		24,709
Cash payments	(2,255)		(9,228)		(11,483)
Accrued restructuring balance as of September 30, 2023	$	419	$	18,055	$	18,474

The accrued restructuring balances as of September 30, 2023 represent estimated future cash payments required to satisfy the Company's remaining obligations, the majority of which are expected to be paid in the next twelve months.

XML

Operating Segment Information

6 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

OPERATING SEGMENT INFORMATION

OPERATING SEGMENT INFORMATION

The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income.

HPA is a leading global supplier of radio frequency ("RF") and power solutions for automotive, defense and aerospace, cellular infrastructure, broadband, industrial, enterprise and consumer markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and 5G and 6G network infrastructure.

CSG is a leading global supplier of connectivity and sensor solutions, with broad expertise spanning ultra-wideband, Matter®, Bluetooth® Low Energy, Zigbee®, Thread®, Wi-Fi®, cellular Internet of Things, microelectromechanical system-based sensors and bulk acoustic wave-based sensors. CSG’s markets include home and consumer electronics, industrial automation, automotive, smartphones, wearables, and industrial and enterprise access points.

ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies.

The "All other" category includes operating expenses such as stock-based compensation expense, amortization of intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill impairment, charges associated with a long-term capacity reservation agreement, fixed asset impairments, (loss) gain on sale of fixed assets and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Revenue:
HPA	$	149,804	$	228,132	$	289,496	$	439,083
CSG	103,622		143,329		202,885		295,644
ACG	850,067		786,596		1,262,276		1,458,688
Total revenue	$	1,103,493	$	1,158,057	$	1,754,657	$	2,193,415
Operating income (loss):
HPA	$	25,446	$	80,512	$	49,410	$	151,266
CSG	(27,725)		(10,019)		(47,886)		1,219
ACG	284,805		267,204		329,803		469,577
All other	(131,098)		(76,135)		(228,035)		(258,641)
Operating income	151,428		261,562		103,292		363,421
Interest expense	(17,121)		(16,904)		(34,382)		(34,156)
Other income (expense), net	5,211		2,214		18,927		(2,848)
Income before income taxes	$	139,518	$	246,872	$	87,837	$	326,417

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Reconciliation of "All other" category:
Stock-based compensation expense	$	(39,053)	$	(31,789)	$	(77,498)	$	(67,203)
Amortization of intangible assets	(29,963)		(32,787)		(60,835)		(66,439)
Restructuring-related charges (1)	(8,418)		(4,544)		(31,154)		(5,094)
Acquisition and integration-related costs	(852)		(8,642)		(2,047)		(14,950)
Goodwill impairment (2)	(48,000)		—		(48,000)		—
Charges associated with a long-term capacity reservation agreement	—		—		—		(110,000)
Other	(4,812)		1,627		(8,501)		5,045
Loss from operations for "All other"	$	(131,098)	$	(76,135)	$	(228,035)	$	(258,641)

(1) Refer to Note 9 for additional information.

(2) Refer to Note 3 for additional information.

XML

Income Taxes

6 Months Ended

Sep. 30, 2023

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The Company’s income tax expense was $42.1 million and $34.0 million for the three and six months ended September 30, 2023, respectively, and income tax expense was $58.3 million and $68.9 million for the three and six months ended October 1, 2022, respectively. The Company’s effective tax rate was 30.1% and 38.7% for the three and six months ended September 30, 2023, respectively, and 23.6% and 21.1% for the three and six months ended October 1, 2022, respectively.

The Company's effective tax rate for the three and six months ended September 30, 2023 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, global intangible low tax income ("GILTI"), domestic tax credits generated, discrete tax items recorded during the period and the effects of a non-deductible goodwill impairment charge within the CSG segment. A discrete tax expense of $5.6 million and $5.5 million was recorded during the three and six months ended September 30, 2023 and primarily resulted from foreign currency gains recognized for tax purposes.

The Company's effective tax rate for the three and six months ended October 1, 2022 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, GILTI, domestic tax credits generated and discrete tax items recorded during the period. A discrete tax expense of $6.7 million and discrete tax benefit of $12.6 million was recorded during the three and six months ended October 1, 2022, respectively. The discrete tax expense for the three months ended October 1, 2022 primarily resulted from foreign currency gains recognized for tax purposes. The discrete tax benefit for the six months ended October 1, 2022 primarily resulted from certain charges associated with a long-term capacity reservation agreement recorded during the first quarter of fiscal 2023.

XML

Net Income Per Share

6 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

NET INCOME PER SHARE

NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Numerator:
Numerator for basic and diluted net income per share — net income available to common stockholders	$	97,461	$	188,615	$	53,881	$	257,499
Denominator:
Denominator for basic net income per share — weighted-average shares	97,945		102,927		98,167		103,991
Effect of dilutive securities:
Stock-based awards	645		747		725		826
Denominator for diluted net income per share — adjusted weighted-average shares and assumed conversions	98,590		103,674		98,892		104,817
Basic net income per share	$	1.00	$	1.83	$	0.55	$	2.48
Diluted net income per share	$	0.99	$	1.82	$	0.54	$	2.46

In the computation of diluted net income per share for the three and six months ended September 30, 2023, approximately 0.8 million and 0.6 million shares, respectively, of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of diluted net income per share for the three and six months ended October 1, 2022, approximately 1.0 million and 0.7 million shares, respectively, of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive.

XML

Pay vs Performance Disclosure - USD ($)
$ in Thousands

3 Months Ended

6 Months Ended

Sep. 30, 2023

Oct. 01, 2022

Sep. 30, 2023

Oct. 01, 2022

Pay vs Performance Disclosure

Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders

$ 97,461

$ 188,615

$ 53,881

$ 257,499

Trading Arrangements, by Individual [Table Text Block]

The following table describes actions by our directors and Section 16 officers with respect to plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) during the second quarter of fiscal 2024. None of our directors or Section 16 officers took actions with respect to a "non-Rule 10b5-1 trading arrangement," as such term is defined in Item 408(c) of Regulation S-K, during the second quarter of fiscal 2024.

Name and Title	Action	Date	Expiration of Plan	Number of Shares to be Sold(1)
Philip J. Chesley Senior Vice President and President of High Performance Analog	Adoption	8/25/2023	8/30/2024	27,898

(1) Represents the gross number of shares subject to the Rule 10b5-1 plan, excluding the potential effect of shares withheld for taxes. Amounts may include shares to be earned as performance-based restricted stock unit awards ("PBRSUs") and are presented at their target amounts. The actual number of PBRSUs earned following the end of the applicable performance period, if any, will depend on the relative attainment of the performance metrics.

XML

Insider Trading Arrangements - shares

3 Months Ended

Aug. 30, 2024

Aug. 25, 2023

Sep. 30, 2023

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

OTHER INFORMATION.

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

The following table describes actions by our directors and Section 16 officers with respect to plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) during the second quarter of fiscal 2024. None of our directors or Section 16 officers took actions with respect to a "non-Rule 10b5-1 trading arrangement," as such term is defined in Item 408(c) of Regulation S-K, during the second quarter of fiscal 2024.

Name and Title	Action	Date	Expiration of Plan	Number of Shares to be Sold(1)
Philip J. Chesley Senior Vice President and President of High Performance Analog	Adoption	8/25/2023	8/30/2024	27,898

(1) Represents the gross number of shares subject to the Rule 10b5-1 plan, excluding the potential effect of shares withheld for taxes. Amounts may include shares to be earned as performance-based restricted stock unit awards ("PBRSUs") and are presented at their target amounts. The actual number of PBRSUs earned following the end of the applicable performance period, if any, will depend on the relative attainment of the performance metrics.

PHILIP CHESLEY [Member]

Trading Arrangements, by Individual

Name

Philip J. Chesley

Title

Senior Vice President and President of High Performance Analog

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

8/25/2023

Termination Date

8/30/2024

Aggregate Available

27,898

XML

Long-Term Debt Fair Value of Debt (Policies)	6 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Fair value of debt [Policy Text Block]	The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of September 30, 2023 was $470.7 million, $751.1 million and $553.8 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 1, 2023 was $464.2 million, $785.9 million and $565.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

XML

Operating Segment Information Segment Policy (Policies)	6 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segment Reporting, Policy [Policy Text Block]	The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income.

XML

Inventories (Tables)

6 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

Components of inventories

The components of inventories, net of reserves, are as follows (in thousands):

	September 30, 2023		April 1, 2023
Raw materials	$	266,354	$	264,367
Work in process	421,295		345,545
Finished goods	152,206		186,684
Total inventories	$	839,855	$	796,596

XML

Goodwill and Intangible Assets (Tables)

6 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

The changes in the carrying amount of goodwill are as follows (in thousands):

	HPA		CSG		ACG		Total
Balance as of April 1, 2023 (1)	$	501,602	$	525,351	$	1,733,860	$	2,760,813
Goodwill impairment	—		(48,000)		—		(48,000)
Effect of changes in foreign currency exchange rates	—		(4,503)		—		(4,503)
Balance as of September 30, 2023 (1)	$	501,602	$	472,848	$	1,733,860	$	2,708,310

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $730.0 million and $682.0 million as of September 30, 2023 and April 1, 2023, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023 and 2024.

Schedule of finite-lived and indefinite-lived intangible assets [Table Text Block]

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):

	September 30, 2023				April 1, 2023
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	863,836	$	430,265	$	872,106	$	382,448
Customer relationships	87,040		58,551		104,616		67,485
Technology licenses	2,224		703		1,664		513
Trade names	910		901		910		789
In-process research and development	9,574		N/A		9,642		N/A
Total (1)	$	963,584	$	490,420	$	988,938	$	451,235

(1) Amounts include the impact of foreign currency translation.

XML

Investments and Fair Value of Financial Instruments (Tables)

6 Months Ended

Sep. 30, 2023

Investments and Fair Value Measurements [Abstract]

Fair value of the financial assets measured at fair value on a recurring basis

The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands):

	Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
September 30, 2023
Marketable equity securities	$	642	$	642	$	—	$	—
Invested funds in deferred compensation plan (1)	42,939		42,939		—		—
April 1, 2023
Marketable equity securities	$	1,094	$	1,094	$	—	$	—
Invested funds in deferred compensation plan (1)	40,653		40,653		—		—
Contingent earn-out liability (2)	(31,250)		—		—		(31,250)

(1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments.

(2) The fair value of the contingent consideration liability which related to the acquisition of United Silicon Carbide, Inc. was equal to the maximum amount payable at April 1, 2023 and was subsequently paid in the first quarter of fiscal 2024.

XML

Debt (Tables)

6 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments

Long-term debt is as follows (in thousands):

	September 30, 2023		April 1, 2023
1.750% senior notes due 2024	$	500,000	$	500,000
4.375% senior notes due 2029	850,000		850,000
3.375% senior notes due 2031	700,000		700,000
Finance leases and other	1,238		1,666
Unamortized premium, discount and issuance costs, net	(2,557)		(3,283)
Less current portion of long-term debt	(96)		(310)
Total long-term debt	$	2,048,585	$	2,048,073

XML

Revenue (Tables)

6 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

Revenue to customers by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
United States	$	699,288	$	615,007	$	1,014,571	$	1,011,038
China	189,900		221,737		340,706		505,213
Other Asia	119,395		126,360		210,729		318,688
Taiwan	66,162		130,463		132,018		221,635
Europe	28,748		64,490		56,633		136,841
Total revenue	$	1,103,493	$	1,158,057	$	1,754,657	$	2,193,415

XML

Restructuring and Related Activities (Tables)

6 Months Ended

Sep. 30, 2023

Restructuring and Related Activities [Abstract]

Schedule of restructuring activity

The following table summarizes the charges resulting from restructuring initiatives (in thousands):

	Three Months Ended September 30, 2023						Six Months Ended September 30, 2023
	Cost of Goods Sold		Other Operating Expense		Total		Cost of Goods Sold		Other Operating Expense		Total
Contract termination and other costs	$	2,482	$	1,328	$	3,810	$	19,278	$	2,757	$	22,035
Asset impairment costs	—		3,646		3,646		2,159		4,286		6,445
One-time employee termination benefits	—		962		962		—		2,674		2,674
Total	$	2,482	$	5,936	$	8,418	$	21,437	$	9,717	$	31,154

Restructuring Liabilities Rollforward

The following table summarizes the activity related to the Company's restructuring liabilities for the six months ended September 30, 2023 (in thousands):

	One-Time Employee Termination Benefits		Contract Termination and Other Costs		Total
Accrued restructuring balance as of April 1, 2023	$	—	$	5,248	$	5,248
Costs incurred and charged to expense	2,674		22,035		24,709
Cash payments	(2,255)		(9,228)		(11,483)
Accrued restructuring balance as of September 30, 2023	$	419	$	18,055	$	18,474

The accrued restructuring balances as of September 30, 2023 represent estimated future cash payments required to satisfy the Company's remaining obligations, the majority of which are expected to be paid in the next twelve months.

XML

Operating Segment Information (Tables)

6 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

Summary of details of reportable segments

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Revenue:
HPA	$	149,804	$	228,132	$	289,496	$	439,083
CSG	103,622		143,329		202,885		295,644
ACG	850,067		786,596		1,262,276		1,458,688
Total revenue	$	1,103,493	$	1,158,057	$	1,754,657	$	2,193,415
Operating income (loss):
HPA	$	25,446	$	80,512	$	49,410	$	151,266
CSG	(27,725)		(10,019)		(47,886)		1,219
ACG	284,805		267,204		329,803		469,577
All other	(131,098)		(76,135)		(228,035)		(258,641)
Operating income	151,428		261,562		103,292		363,421
Interest expense	(17,121)		(16,904)		(34,382)		(34,156)
Other income (expense), net	5,211		2,214		18,927		(2,848)
Income before income taxes	$	139,518	$	246,872	$	87,837	$	326,417

Summary of reconciliation of "All other" category

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Reconciliation of "All other" category:
Stock-based compensation expense	$	(39,053)	$	(31,789)	$	(77,498)	$	(67,203)
Amortization of intangible assets	(29,963)		(32,787)		(60,835)		(66,439)
Restructuring-related charges (1)	(8,418)		(4,544)		(31,154)		(5,094)
Acquisition and integration-related costs	(852)		(8,642)		(2,047)		(14,950)
Goodwill impairment (2)	(48,000)		—		(48,000)		—
Charges associated with a long-term capacity reservation agreement	—		—		—		(110,000)
Other	(4,812)		1,627		(8,501)		5,045
Loss from operations for "All other"	$	(131,098)	$	(76,135)	$	(228,035)	$	(258,641)

(1) Refer to Note 9 for additional information.

(2) Refer to Note 3 for additional information.

XML

Net Income Per Share (Tables)

6 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Reconciliation of the numerators and denominators in the computation of basic and diluted net loss per share

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):

	Three Months Ended				Six Months Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Numerator:
Numerator for basic and diluted net income per share — net income available to common stockholders	$	97,461	$	188,615	$	53,881	$	257,499
Denominator:
Denominator for basic net income per share — weighted-average shares	97,945		102,927		98,167		103,991
Effect of dilutive securities:
Stock-based awards	645		747		725		826
Denominator for diluted net income per share — adjusted weighted-average shares and assumed conversions	98,590		103,674		98,892		104,817
Basic net income per share	$	1.00	$	1.83	$	0.55	$	2.48
Diluted net income per share	$	0.99	$	1.82	$	0.54	$	2.46

XML

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Apr. 01, 2023
Components of inventories
Raw materials	$ 266,354	$ 264,367
Work in process	421,295	345,545
Finished goods	152,206	186,684
Total inventories	$ 839,855	$ 796,596

XML

Business Acquisition Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Apr. 01, 2023
Business Acquisition [Line Items]
Goodwill	$ 2,708,310	$ 2,760,813

XML

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Apr. 01, 2023
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization			$ 61,103	$ 66,539
Goodwill	$ 2,708,310		2,708,310		$ 2,760,813
Goodwill, Impairment Loss	48,000	$ 0	48,000	$ 0
Goodwill, Accumulated impairment losses and write-offs	730,000		730,000		682,000
Accumulated Amortization	490,420		490,420		451,235
Goodwill, Foreign Currency Translation Gain (Loss)			(4,503)
Gross Carrying Amount	963,584		963,584		988,938
Technology licenses
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	2,224		2,224		1,664
Accumulated Amortization	703		703		513
Trade Names
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	910		910		910
Accumulated Amortization	901		901		789
Developed Technology
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	863,836		863,836		872,106
Accumulated Amortization	430,265		430,265		382,448
Customer Relationships
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	87,040		87,040		104,616
Accumulated Amortization	58,551		58,551		67,485
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD	9,574		9,574		9,642
HPA
Goodwill and Intangible Assets [Line Items]
Goodwill	501,602		501,602		501,602
Goodwill, Impairment Loss			0
Goodwill, Foreign Currency Translation Gain (Loss)			0
CSG
Goodwill and Intangible Assets [Line Items]
Goodwill	472,848		472,848		525,351
Goodwill, Impairment Loss			48,000
Goodwill, Foreign Currency Translation Gain (Loss)			(4,503)
ACG
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 1,733,860		1,733,860		$ 1,733,860
Goodwill, Impairment Loss			0
Goodwill, Foreign Currency Translation Gain (Loss)			$ 0

XML

Investments and Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Apr. 01, 2023
Investments and Fair Value of Financial Instruments
Document Period End Date			Sep. 30, 2023
Equity Method Investments	$ 18,500		$ 18,500		$ 20,400
Proceeds from Limited Partnership Investments	2,300	$ 0	2,800	$ 2,000
Gain (Loss) on Investments	1,200	$ 1,200	900	$ 400
Fair Value, Recurring [Member] | United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent					(31,250)
Fair Value, Recurring [Member] | Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	642		642		1,094
Fair Value, Recurring [Member] | Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	42,939		42,939		40,653
Quoted Prices In Active Markets For Identical Assets (Level 1) | Fair Value, Recurring [Member] | United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent					0
Quoted Prices In Active Markets For Identical Assets (Level 1) | Fair Value, Recurring [Member] | Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	642		642		1,094
Quoted Prices In Active Markets For Identical Assets (Level 1) | Fair Value, Recurring [Member] | Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	42,939		42,939		40,653
Significant Other Observable Inputs (Level 2) | Fair Value, Recurring [Member] | United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent					0
Significant Other Observable Inputs (Level 2) | Fair Value, Recurring [Member] | Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	0		0		0
Significant Other Observable Inputs (Level 2) | Fair Value, Recurring [Member] | Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	0		0		0
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent					(31,250)
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	0		0		0
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	$ 0		$ 0		$ 0

XML

Debt (Details) - USD ($)		3 Months Ended		6 Months Ended
	Apr. 06, 2022	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Jun. 29, 2024	Dec. 30, 2023	Apr. 01, 2023	Dec. 14, 2021	Sep. 29, 2020	Jun. 11, 2020	Dec. 20, 2019	Sep. 30, 2019
Debt Instrument [Line Items]
Long-term debt		$ 2,048,585,000		$ 2,048,585,000				$ 2,048,073,000
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net		(2,557,000)		(2,557,000)				(3,283,000)
Long-term Debt, Current Maturities		(96,000)		(96,000)				(310,000)
Interest Expense, Borrowings		17,900,000	$ 17,900,000	36,100,000	$ 36,100,000
Interest Costs Capitalized		800,000	1,000,000	1,700,000	2,000,000
Interest expense		17,121,000	$ 16,904,000	34,382,000	$ 34,156,000
Line of Credit Facility, Remaining Borrowing Capacity										$ 500,000,000
4.375% senior notes due 2029
Debt Instrument [Line Items]
Debt Instrument, Face Amount		850,000,000		850,000,000				850,000,000			$ 300,000,000	$ 200,000,000	$ 350,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities		0		18,600,000
Debt Instrument, Interest Rate, Stated Percentage													4.375%
4.375% senior notes due 2029 | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		751,100,000		751,100,000				785,900,000
3.375% Senior Notes due 2031 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount		700,000,000		700,000,000				700,000,000		$ 700,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities		0		11,800,000
Debt Instrument, Interest Rate, Stated Percentage										3.375%
3.375% Senior Notes due 2031 [Member] | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		553,800,000		553,800,000				565,300,000
Senior Notes Due 2024 1.750%
Debt Instrument [Line Items]
Debt Instrument, Face Amount		500,000,000		500,000,000				500,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities		0		4,400,000
Debt Instrument, Interest Rate, Stated Percentage									1.75%
Senior Notes Due 2024 1.750% | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		$ 470,700,000		$ 470,700,000				464,200,000
Credit Agreement | Federal Funds Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Agreement | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.00%
Credit Agreement | Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Consolidated Leverage Ratio		400.00%		400.00%
Credit Agreement | Maximum [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Debt Instrument, Consolidated Leverage Ratio						300.00%	350.00%
Credit Agreement | Maximum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.25%
Credit Agreement | Maximum [Member] | Loan Lending Commitment Arrangement Fees [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.20%
Credit Agreement | Maximum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.25%
Credit Agreement | Minimum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.00%
Credit Agreement | Minimum [Member] | Loan Lending Commitment Arrangement Fees [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.15%
Credit Agreement | Minimum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.00%
Capital Lease Obligations
Debt Instrument [Line Items]
Long-term debt		$ 1,238,000		$ 1,238,000				$ 1,666,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity										$ 300,000,000
Proceeds from Lines of Credit				$ 0

XML

Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Nov. 02, 2022
Class of Stock [Line Items]
Stock Repurchased During Period, Shares	1.0	1.7	2.0	4.9
Stock Repurchased During Period, Value	$ 100,554	$ 160,057	$ 201,166	$ 510,099
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 1,505,000		$ 1,505,000
Document Period End Date			Sep. 30, 2023
November 2, 2022 Program
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount					$ 2,000,000

XML

Commitments and Contingent Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 30, 2023	Jul. 02, 2022	Sep. 30, 2023
Unrecorded Unconditional Purchase Obligation [Line Items]
Charges associated with a long-term capacity reservation agreement		$ 110.0	$ 0.0
Subsequent Event [Member]
Unrecorded Unconditional Purchase Obligation [Line Items]
Charges associated with a long-term capacity reservation agreement	$ 65.0

XML

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Disaggregation of Revenue
Revenues	$ 1,103,493	$ 1,158,057	$ 1,754,657	$ 2,193,415
China
Disaggregation of Revenue
Revenues	189,900	221,737	340,706	505,213
Taiwan
Disaggregation of Revenue
Revenues	66,162	130,463	132,018	221,635
United States
Disaggregation of Revenue
Revenues	699,288	615,007	1,014,571	1,011,038
Europe
Disaggregation of Revenue
Revenues	28,748	64,490	56,633	136,841
Other Asia
Disaggregation of Revenue
Revenues	$ 119,395	$ 126,360	$ 210,729	$ 318,688

XML

Restructuring and Related Activities (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Apr. 01, 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges		$ 24,709
Restructuring
Restructuring Charges		24,709
Payments for Restructuring		(11,483)
Restructuring Reserve	$ 18,474	18,474	$ 5,248
One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges		2,674
Restructuring
Restructuring Charges		2,674
Payments for Restructuring		(2,255)
Restructuring Reserve	419	419	0
Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges		22,035
Restructuring
Restructuring Charges		22,035
Payments for Restructuring		(9,228)
Restructuring Reserve	18,055	18,055	$ 5,248
fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	8,418	31,154
Restructuring
Restructuring Charges	8,418	31,154
fiscal year 2023 | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	962	2,674
Restructuring
Restructuring Charges	962	2,674
fiscal year 2023 | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	3,646	6,445
Restructuring
Restructuring Charges	3,646	6,445
fiscal year 2023 | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	3,810	22,035
Restructuring
Restructuring Charges	3,810	22,035
Other operating expense | fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	5,936	9,717
Restructuring
Restructuring Charges	5,936	9,717
Other operating expense | fiscal year 2023 | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	962	2,674
Restructuring
Restructuring Charges	962	2,674
Other operating expense | fiscal year 2023 | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	3,646	4,286
Restructuring
Restructuring Charges	3,646	4,286
Other operating expense | fiscal year 2023 | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	1,328	2,757
Restructuring
Restructuring Charges	1,328	2,757
Cost of goods sold | fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	2,482	21,437
Restructuring
Restructuring Charges	2,482	21,437
Cost of goods sold | fiscal year 2023 | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	0	0
Restructuring
Restructuring Charges	0	0
Cost of goods sold | fiscal year 2023 | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	0	2,159
Restructuring
Restructuring Charges	0	2,159
Cost of goods sold | fiscal year 2023 | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	2,482	19,278
Restructuring
Restructuring Charges	$ 2,482	$ 19,278

XML

Operating Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Jul. 02, 2022	Sep. 30, 2023	Oct. 01, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Document Period End Date				Sep. 30, 2023
Summary of details of reportable segments
Revenues	$ 1,103,493	$ 1,158,057		$ 1,754,657	$ 2,193,415
Income from operations:
Operating income	151,428	261,562		103,292	363,421
Interest expense	17,121	16,904		34,382	34,156
Other income (expense), net	5,211	2,214		18,927	(2,848)
Income before income taxes	139,518	246,872		87,837	326,417
Stock-based compensation expense				(77,498)	(67,203)
Amortization of intangible assets				(61,103)	(66,539)
Restructuring Charges				(24,709)
Charges associated with a long-term capacity reservation agreement			$ 110,000	0
Goodwill, Impairment Loss	(48,000)	0		(48,000)	0
HPA
Income from operations:
Goodwill, Impairment Loss				0
CSG
Income from operations:
Goodwill, Impairment Loss				(48,000)
ACG
Income from operations:
Goodwill, Impairment Loss				0
Operating Segments | HPA
Summary of details of reportable segments
Revenues	149,804	228,132		289,496	439,083
Income from operations:
Operating income	25,446	80,512		49,410	151,266
Operating Segments | CSG
Summary of details of reportable segments
Revenues	103,622	143,329		202,885	295,644
Income from operations:
Operating income	(27,725)	(10,019)		(47,886)	1,219
Operating Segments | ACG
Summary of details of reportable segments
Revenues	850,067	786,596		1,262,276	1,458,688
Income from operations:
Operating income	284,805	267,204		329,803	469,577
All other
Income from operations:
Operating income	(131,098)	(76,135)		(228,035)	(258,641)
Stock-based compensation expense	(39,053)	(31,789)		(77,498)	(67,203)
Amortization of intangible assets	(29,963)	(32,787)		(60,835)	(66,439)
Restructuring Charges	(8,418)	(4,544)		(31,154)	(5,094)
Acquisition and integration-related costs	(852)	(8,642)		(2,047)	(14,950)
Charges associated with a long-term capacity reservation agreement	0	0		0	110,000
Other	$ (4,812)	$ 1,627		$ (8,501)	$ 5,045

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Income Tax Disclosure [Abstract]
Income tax benefit (expense)	$ 42,057	$ 58,257	$ 33,956	$ 68,918
Effective tax rate	30.10%	23.60%	38.70%	21.10%
Discrete tax expense (benefit)	$ (5,600)	$ (6,700)	$ (5,500)	$ 12,600

XML

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Earnings Per Share [Abstract]
Document Period End Date			Sep. 30, 2023
Numerator:
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ 97,461	$ 188,615	$ 53,881	$ 257,499
EPS Line Items
Denominator for basic net income (loss) per share — weighted average shares	97,945	102,927	98,167	103,991
Stock-based awards	645	747	725	826
Denominator for diluted net income (loss) per share — adjusted weighted average shares and assumed conversions	98,590	103,674	98,892	104,817
Basic net income (loss) per share (in dollars per share)	$ 1.00	$ 1.83	$ 0.55	$ 2.48
Diluted net income (loss) per share (in dollars per share)	$ 0.99	$ 1.82	$ 0.54	$ 2.46
Antidilutive shares excluded from the computation of diluted shares outstanding	800	1,000	600	700